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ABSTRACT 
 Catharanthus roseus is a medicinal shrub plant used in traditional medicine 
treatment by local in India, South Africa, China and Malaysia for diabetes. Six known 
alkaloids and one new alkaloid namely, vindoline, vindolinine, perivine, vindorosine, 
vindolicine, serpentine and vindogentianine were isolated and identified from 
dichloromethane extract of Catharanthus roseus’ leaves.  
The leaves dichloromethane extract of Catharanthus roseus and alkaloids were 
not cytotoxic towards β-TC6 cells at 50.0 µg/mL except vindolinine and perivine with 
IC50 at 20.5 ± 3.6 and 46.7 ± 4.4 µg/mL. All five alkaloids tested showed higher glucose 
uptake in β-TC6 cells at treatment of 12.5 µg/mL and 25.0 µg/mL compared with 
untreated cells. Vindorosine, vindolicine and vindogentianine were shown to possess in 
vitro hypoglycemic activity for the first time. Vindolicine demonstrated highest 
hypoglycemic activity in glucose uptake and PTP-1B inhibition assay. The isolated 
alkaloid compounds could be responsible for the antidiabetic effect in Catharanthus 
roseus extracts and provide an explanation to its traditional usage.  
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ABSTRAK 
 Catharanthus roseus adalah satu tumbuhan herba ubatan yang digunakan oleh 
orang tempatan dalam perubatan tradisional di India, Afrika Selatan, China dan 
Malaysia untuk mengubati penyakit kencing manis. Enam alkaloid yang pernah 
dijumpai dan satu alkaloid baru: vindolin, vindolinin, perivin, vindorosin, vindolicin, 
serpentin dan vindogentianin telah berjaya diasingkan dan dikenal pasti daripada ekstrak 
dikhlorometane daun Catharanthus roseus (DE).  
Hanya vindolinin dan perivin didapati membunuh cell β-TC6 pada kepekatan 
50.0 µg/mL dengan IC50 20.5 ± 3.6 and 46.7 ± 4.4 µg/mL. Kesemua lima alkaloid yang 
diuji menunjukkan meningkatan pengambilan gula dalam cell β-TC6 cells pada 
kepekatan 12.5 µg/mL and 25.0 µg/mL berbanding dengan cell yang tiada rawatan. 
Vindorosin, vindolicin and vindogentianin telah menunjuk activiti in vitro 
hypoglycemik untuk kali pertama. Vindolicin menunjukkan aktiviti hypoglycemik yang 
paling tinggi dalam penilaian pengambilan gula dan pembantutan PTP-1B. Alkaloid 
yang telah didapati daripada ekstrak daun Catharanthus roseus didapati 
bertanggungjawab ke atast aktiviti antidiabetik yang diperhatikan. Justeru, menyokong 
kebolehan tumbuhan ini dalam merawat penyakit kencing manis dalam perubatan 
traditional tempatan.  
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1.1 Introduction 
Nature has been providing food-stuffs, shelters, clothing, means of 
transportation, fertilizers, flavours and fragrances and not least, medicines for humans 
throughout our civilization. The thousands years old traditional medicine system 
continues to provide mankind with new remedies
1
 or insight for drug discovery.  
Drug discovery from medicinal plants involve numerous scientific fields and 
various method of analysis. It begins with botanists, ethnobotanists, 
ethnopharmacologists or plant ecologists who collect and identify the plants. Natural 
product chemists will prepare extracts from the plant materials before subjecting these 
extracts to biological screening together with isolation and characterization of the active 
compounds through bioassay-guided fractionation. Molecular biologists will determine 
and implement appropriate screening assays directed toward physiologically relevant 
molecular targets.
2
 
The natural products field had been and still productive. In the period of 
01/1981-12/2010, there were only 29% of the new chemical entities that were approved 
as drug for treatment were synthetic in origin. Thus, reflecting the big contribution of 
natural product, other than synthetic on drug discovery and approval. The best selling 
drug of all is atorvastin (1), a hypocholesterolemic descended directly from a natural 
product, which sold over $ 11 billion in 2004.
3
  
Newman et al. (2012) reported that over half of drugs approved as antibacterial, 
antiviral, antiparasitic and anticancer were naturally derived products. However, there 
had been a decline in the research and development programs output of the 
pharmaceutical companies with a drop in the number of drugs launched during 2003 to 
2010.
3
 However, there were two approved drugs that mark the breakthrough of natural 
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products during that period, Prialt and Hemoxin.  Prialt is a peptide toxin for pain relief 
from cone snail, a marine organism. It was the first approved pharmaceutical from the 
sea. Hemoxin is a mix of plants that came from native healer in Nigeria for treatment of 
sickle cell anemia. Therefore, Hemoxin can be regarded as a true ethnobotanical 
prepared medicine.
4
  
N
H
N OH
O OOHOH
F
(1)  
However, there were only 37 approved antidiabetic drugs in the period of 30 
years from 1981 to 2010. Out of the 37 drugs approved only 5 or 16.2% were from 
natural or inspired from natural, while a big proportion of 48.6% are peptide from 
biological.
3
 Although antidiabetic drugs from nature were only a small contributor, 
there are still high potential in natural product, especially plants as the source of 
antidiabetic drugs. 45 medicinal plants in India showed varying degree of hypoglycemic 
and anti-hyperglycemic activity.
5
 In traditional Chinese medical system, there were 86 
natural (82 from plants and 4 from animals or insects) medicines were utilized in 
therapy of diabetes mellitus.
6
  
Diabetes mellitus is a chronic metabolic disorder that results from a failure of 
the body to produce the hormone insulin and/or inability of the body to respond 
adequately for insulin circulation.
7
 There are 2 major types out of 5 classification 
introduced by American Diabetes Association; type 1 and type 2 diabetes. Type 1 
diabetes is also known as insulin dependent diabetes because the patient loses the ability 
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to secrete insulin due to selective autoimmune destruction of pancreatic β-cells.7-9 The 
most common type 2 diabetes is also known as non-insulin dependent diabetes because 
the body does not respond well to insulin and the normal insulin level produce by 
pancreas aren’t sufficient. Type 2 diabetes is becoming more common due to increasing 
obesity and failure to exercise especially win urban lifestyles.
8
  
Diabetes has become the third most common disease that heavily threatens 
human health around the world, following cardiovascular diseases and cancers. The 
latest data from the World Health Organization (WHO) approximates there are 346 
million people worldwide are living with diabetes today. It is estimated that the number 
of people with diabetes will double by 2030. To date, no cure had been identified.
7; 10
  
In Malaysia, the number of diabetic has increased by almost 80% in the last 10 
years from 1996-2006 to 1.4 million adults above the age of 30. This number had 
increase about two fold to 3 million now. The Malaysian National Health Morbidity 
Survey III (NHMS III) conducted in 2006 show that our national prevalence of diabetes 
was 14.9% which we observed about 80% rise from 8.3% in NHMS II. Out of the 
majority patients (70%) that were on oral medication, only 7.2% were on insulin alone 
or in combination. Meanwhile, only 0.6% took traditional medicine for diabetes. 
However, patients were known to combine prescribed medications with alternative 
treatment including the use of local herbs in real clinical practice.
11
  
 The use of herbal medicines for treatment of diabetes mellitus has gain attention 
throughout the world. WHO also had recommended and encouraged this practise in 
1980. Although oral hypoglycaemic agents/insulin are the mainstay of the treatment but 
it have prominent side effects and fail significantly in altering the course of diabetes’ 
complication. Therefore, many people are turning to complementary therapies which are 
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medicinal plants arising from indigenous medicines such as Catharanthus roseus that 
was widely used for the treatment of diabetes especially in Asia and Africa.  
1.2 Catharanthus roseus the antidiabetic medicinal plant  
Catharanthus roseus (L.) G. Don was a renowned medicinal plant from the family 
of Apocynaceae.
12
 It was also known as Madagascar Periwinkle and Linnaeus named it 
as Vinca rosea in the 10
th
 edition of his Systema Naturae in 1759. In 1837, G. Don 
observed many botanical differences between Vinca and the Madagascar Periwinkle 
which he later moved to a separate genus Catharanthus.
13
 
Catharanthus roseus was indigenous to Madagascar. It has been widely cultivated 
as ornamental
13
 for hundreds of years and can be found growing wild in most warm 
regions of the world.
12
 The plant was commonly grown in gardens for beddings, borders 
and for mass effect. It blooms throughout the year and is propagated by seeds or 
cuttings.
12
 In the more temperate regions, the plant can only be used as an indoor annual 
potplant because it will die at first frost during winter if placed outdoor. Otherwise, a 
conservatory or greenhouse was usually recommended to keep the plant alive and 
flowering all year long in temperate regions.
12
 
 The leaves of Catharanthus roseus were used in traditional medicine as an oral 
hypoglycemic agent and the study of this activity led to the discovery of two terpenoid 
indole alkaloids, vinblastine (2) and vincristine (3), the first natural anticancer agents to 
be clinically used. Since the discovery of these two bisindole alkaloids from 
Catharanthus roseus, studies were concentrated onto the anticancer activity and less 
into the antidiabetes activity from this plant. 
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N
R1
N
OAc
HO
H
COOMe
MeO
N
H
N
H
HMeOOC
OH
(2), R1=CH3
(3), R1=CHO  
Herbal diabetic treatments using Catharanthus roseus were popularly used 
because it has high therapeutic effect with minimum side effects and were cost 
effective. Catharanthus roseus was widely used in the treatment of diabetes especially 
in India
14
 and South Africa
15
. In Malaysia, the decoction of Catharanthus roseus was 
used to treat diabetes, reduce blood pressure, insomnia and cancer.
16
 The local native 
tribe of Temuan in Malaysia had been reported to cultivate Catharanthus roseus as a 
medicinal plant.
17
  
 The twig and leaves of Catharanthus roseus showed significant increase of 
glucose utilisation in organic and aqueous extract.
15
 The sap of fresh leaves had reduced 
blood glucose in alloxan-treated rabbits.
18
 Another study showed that 
dichloromethane:methanol (1:1) extract of flowering twigs possess antidiabetic activity 
in streptozotocin-induced diabetic rat. There was significant increase in glucokinase 
activity in the rats’ liver treated. Thus, suggesting there were an increase in utilization of 
glucose as the mechanism.
19
 
 The hypoglycemic activity from Catharanthus roseus was due to the presence of 
phytochemical such as vindoline (4), tetrahydroalstonine (5), catharanthine (6), 
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lochnericine (7), leurosine (8), vindolinine (9), adenosine (10), β-sitosterol (11), 
quercetin (12), ursolic acid (13) and tannic (14).
20-22
    
 Recent researches on the antidiabetic activity of Catharanthus roseus was 
orientated toward producing the right herbal medicine for treatment of diabetes by 
evaluation of diabetes complication and side effect of diabetes drug with introduction 
Catharanthus roseus extract.
23
 Researchers were interested to study the synergistic 
effect of drug and plant extract by co-administration.
24
 Another study had been 
conducted to determine the safety of gliclazide (15), an anti-diabetic drug usage 
together with aqueous extract of Catharanthus roseus.
21
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1.3 Apocynaceae 
This family name was given by A.L. de Jussieu in 1789.
13
 Apocynaceae can also 
be known as periwinkle family which it consist of 180 genera and 1500 species. It is of 
mostly tropical distribution with a few in temperate regions.
25
  
Apocynaceae species are usually twining shrubs and rarely erect with latex. 
Their leaves are simple of opposite or alternate or in whorls of 3 with close parallel 
lateral veins. They have panicle, cyme or raceme inflorescence or solitary flower with 
presence of bracts and bracteoles.
25
    
Some plants from this family had been used as economic and ornamental plants. 
Carissa macrocarpa (C. grandiflora), Natal plum and C. carandas are grown for their 
edible fruit. Hancornia speciosa, Mangabeira also has edible fruit but in addition the 
sap is a source of rubber in South America. Silk Rubber is obtained from Funtumia 
elastica. The seeds of various species of Strophanthus have long been used for arrow 
poisons in Africa and some have been accepted as useful drugs in Western medicine. 
Nerium oleander, Oleander and Plumeria rubra, Frangipani have been used as 
decorative plants for warm regions or glasshouse cultivation in cooler climate.
25
 
This family is divided into 2 subfamilies and 5 tribes as shown in Table 1.2 
below. 
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Table 1.1: Classification of the plants in the family of Apocynaceae.
25
 
Family Subfamily Tribe Subtribe  
Apocynaceae Plumerioideae  Arduineae Landolphia  
Carissa 
Allemanda 
Pleiocarpeae Pleiocarpa 
Plumerieae  Rauwolfia 
Tabernaemontana 
Alyxia 
Aspidosperma  
Ochrosia  
Amsonia 
Plumeria 
Vinca 
Catharanthinae 
Apocyniodeae  Apocyneae Mandevilla  
Strophanthus  
Dipladenia 
Apocynum 
Nerium  
Parsonsieae  Parsonsia  
Prestonia  
Forsteronia  
 
1.4 Catharanthus G.Don 
The Catharanthus genus belongs to the subtribe Catharanthinae in the tribe 
Plumerieae, subfamily Plumeroideae within the family of Apocynaceae. This genus 
comprises of eight species namely Catharanthus roseus, Catharanthus trichophyllus, 
Catharanthus lanceus, Catharanthus ovalis, Catharanthus longifolius, Catharanthus 
scitulus, Catharanthus coriaceus and Catharanthus pusillus.
13
 
Catharanthus are annual or perennial herbs or undershrubs which are often with 
white latex and woody at the base. It has herbaceous to fleshy-coriaceous leaves with 
terminal or axillary inflorescences. It has 5-merous and actinomorphic flowers with 
narrowly to narrowly triangular sepals. It has salver-form corolla that come in purple, 
red, pink or white colour.
13
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Out of the eight species, seven are endemic to Madagascar and one 
(Catharanthus pusillus) is endemic to India. Several species grow more or less in the 
same area within Madagascar but their core area can be distinguished. Catharanthus 
trichophyllus can be found mostly in the north-western part of Madagascar. Within the 
central part of Madagascar, Catharanthus lanceus core area is around Antananarivo, 
Catharanthus coriaceus around Itremo Mts., Catharanthus ovalis around Parc Isalo and 
Catharanthus longifolius around Ambalavao. Catharanthus scitulus can be found in 
south-central part of Madagascar. Catharanthus roseus is thought to originate from Fort 
Dauphin area at the most south-eastern part of Madagascar. However, Catharanthus 
roseus has been cultivated as ornamental all over the tropics and subtropic.
13
 As a 
result, it is now naturalized in many countries and escaped in many areas of 
Madagascar.
25
 
In 1753, Linnaeus described the genus Vinca with two species namely Vinca 
major and Vinca minor. He added Vinca rosea to this group four years later. 
Reichenbach separated Vinca rosea from other species in the genus Vinca and giving 
Lochnera as the generic name for the species in 1828. Endlicher made a clear 
distinction between the genus Vinca and Lochnera in his Genera Plantarum which was 
published in August 1838. However, George Don had published the first part of his 
General System of Gardening and Botany volume IV which he also made a separation 
between the species in genus Vinca and giving the name Catharanthus as the new genus 
in 1837. Therefore, Catharanthus got priority over Lochnera which was published one 
year later.
13
 
1.5 Catharanthus roseus 
Catharanthus roseus is an undershrub plant that grows to 30-100 cm high, either 
erect or decumbent with white latex and come with unpleasant smell. Its trunk can grow 
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up to 1 cm in diameter and pale grey in colour. It has terete, narrowly winged, green or 
dark red, pilose or glabrous stem. It has decussate and petiolate leaves. Its flowers are 
axillary, solitary or paired, pendunculate 1-4 mm long, narrowly winged and glabrous or 
pilose. It has medium green sepals and pink, magenta or white with darker center, paler 
or whitish outside corolla lobes. The fruits are green or pale green and seeds are black.
13
 
Catharanthus roseus are found at the altitude of 0-900 m on coral sand, beaches 
and limestone rocks. It can also survive in open forests, ruderal places, along roadsides 
in dry shrub woodland or grassland.  As the result of the high survivability in wide 
variety of habitat and flowering throughout the year, it has been naturalized and 
cultivated as indoor or garden plants all over the tropic and subtropics.
2
  
In Malaysia, Catharanthus roseus has also been cultivated and naturalized 
throughout the country.  This plant is known by the locals with a few names such as 
Tahi Ayam, Kemuning Cina,
26
 Kembang Sari Cina, Kemunting Cina, Rumput Jalang 
and Tapak Dara.
27; 28
 
Cultivation of this plant has been going on for a very long time. Even before it 
was studied for its medicinal value, it was cultivated as a garden or decorative plant. 
The seed of this plant was first sent to the Royal Gardens in Versailles near Paris from 
Madagascar.
13
 
In 1661, the hypotensive effect of the root extract was reported. Around 1930, 
pharmacologists were attracted to study its antidiabetic activity due to its traditional use 
against diabetes. This experiment was repeated at the 1950’s, but the test animals 
became seriously ill. As the result, Noble and co-workers discovered vinblastine (2) as 
an unexpected myelosuppressive agent in 1958 during their search for an antidiabetic 
agent in Catharanthus roseus.
29
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Independently, researchers at Eli Lily found extracts of Catharanthus roseus 
possessed activity against P-1534 leukaemia in mice and isolated vinblastine (2) as its 
active entity in 1959. The structure of a related compound, vincristine methiodide was 
then determined by an x-ray crystallography in 1965.
30
 Vinblastine (2) and vincristine 
(3) were the first natural anticancer agents to be clinically used.
31
  
 
1.6 Objectives of the study 
In continuing interest to investigate Malaysian medicinal plants, the author has 
embarked on a study of the antidiabetic agents from Catharanthus roseus. The 
objectives of this study are as follows: 
I. To isolate the alkaloids constituents in the leaves of Malaysian 
Catharanthus rosues. 
II. To identify the alkaloids constituents isolated from the leaves of 
Malaysian Catharanthus roseus by spectroscopic methods.  
III. To evaluate the cytotoxicity of the alkaloids isolated against normal 
pancreas cells (β-TC6) 
IV. To evaluate the antidiabetic activity of the alkaloids by glucose uptake in 
β-TC6 cells while studying it possible mechanism by PTP-1B inhibition 
of some most promising alkaloids as antidiabetic agent.   
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Figure 1.1: Catharanthus roseus. 1, habit (×2/3); 2, flower (×2/3); 3, bud (×2/3); 4, 
pistil (×6 2/3); 5, anthers (×6 2/3); 6, fruit (×2/3); 7, seed, back side (×6 2/3); 8, seed, 
hillar side (×6 2/3); 9, detail stem (×3 2/3); 10, 11, 12, leaves (×2/3).
13
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2.1 Chemical constituents of Catharanthus roseus 
 Catharanthus roseus is a well known Apocynaceae medicinal plant, rich with 
indole alkaloids. However, this plant also consists of other valuable constituents in 
addition to indole alkaloids such as phenolics, terpene and others.  
 R.Verpoorte et al. reviewed the occurrence of phenolic compounds such as 2,3-
dihydrobenzoic acid, phenylpropanoids, flavonoids and athnocyanins in Catharanthus 
roseus.
32
 Ferreres et al. conducted a study on noncoloured phenolics in Catharanthus 
roseus, which allowed characterization of three caffeoylquinic acids and fifteen new 
flavonol glycosides.
31
 K.Toki et al. and I.M.Chung et al. research had showed more 
new and interesting phenolic compounds from Catharanthus roseus.
33; 34
 P.Guedes De 
Pinho et al. had identified a total of 88 volatile and semi-volatile component which 
including diterpenic compounds, sesquiterpenes and some pyridine, pyrazine, indole 
and carotenoid derivatives.
35
  
 Indole alkaloids are commonly found in plants from the family of Apocynaceae, 
Loganiaceae and Rubiaceae as monoterpene indole alkaloids. Plants from the families 
of Leguminoseae, Rutaceae, Simaroubaceae, Zygophyllaceae, Elaeocarpaceae and 
Alangiaceae are also known to have indole alkaloids but are less studied.  In 
Apocynaceae, indole alkaloids are known to be present in 32 genera such as Hunteria, 
Kopsia, Alstonia, etc. These indole alkaloid-bearing genera of Apocynaceae come from  
the same subfamily of Plumeriodeae and are represented by 4 tribes, Carisseae, 
Tabernaemontaneae, Rouvolfieae and Plumerieae (Table 2.1).
36
   
 Leeuwenberg in 1980 had categorized monoterpene indole alkaloids into eight 
main skeletal types: corynanthean, strychnan, ibogan, plumeran, eburnan, 
aspidospermatan, vallensiachotaman and vincosan. (Figure 2.1) Beside these eight types 
of indole alkaloids, there were other unknown and miscellaneous types that were not 
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covered by Leeuwenberg. Eventhough there were other catergorization of indole 
alkaloids were reported, the author found the classification by Leeuwenberg was less 
complicated and have clear relationship showed in between each skeleton of indole 
alkaloids (Figure  2.1).
36
  
Table 2.1: Genera of Apocynaceae which have species containing indole alkaloids.
36
  
Family Subfamily Tribe Subtribe Genera 
A
p
o
cy
n
ac
ea
e 
P
lu
m
er
io
id
ea
e 
C
ar
is
se
ae
 
Carissinae  Melodinus  
Leuconotis  
Landolphiinae  Landolphia  
Pleiocarpinae Picralina  
Hunteria  
Pleiocarpa  
T
ab
er
n
ae
m
o
n
ta
n
ea
e - Crioceras  
Callichilia  
Stemmadenia  
Capuronetta  
Tabernaemontana  
Tabernathe  
Voacanga  
Schizoxygia  
R
o
u
v
o
lf
ie
ae
 Rauvolfiinae Cabucala  
Rauvolfia  
Ochrosiinae  Ochrosia  
Vallesiinae  Vallesia  
Kopsia  
Condylocarpinae  Condylocarpon  
P
lu
m
er
ie
ae
 
(A
ls
to
n
ie
ae
) 
Craspidosperminae  Craspidospermum 
Plectaneiinae  Gonioma  
Alstoniinae  Alstonia  
Tonduzia  
Aspidospermatinae  Diplorhynchus  
Aspidosperma  
Geissosperum  
Catharanthinae  Rhazya  
Amsonia 
Catharanthus  
Vinca  
Haplophyton  
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 Catharanthus roseus as a species from the tribe of Plumerieae and subtribe of 
Catharanthine has more than 130 indole alkaloids with more than 25 being dimeric 
bisindoles. Bisindoles from Catharanthus roseus found to be derived from monomers of 
one or two main skeletal types but mostly are from plumeran and ibogan type. Even 
after thorough and comprehensive investigations of the chemical constituents from this 
plant, recently Wang et al. (2011) still able to report three new indole alkaloids from 
this plant.
37
 Table 2.2 list down all the indole alkaloids that had been reported from 
Catharanthus roseus. 
Table 2.2: Known alkaloids according to biogenetic class isolated from  
Catharanthus roseus. 
Alkaloids Class Alkaloids Class 
Vinblastine (2)
38
  B Vincristine (3)
39
  B 
Vindoline (4)
38
  P Tetrahydroalstonine (5)
40
  C 
Catharanthine (6)
40
  I Lochnericine (7)
41
  P 
Leurosine (8)
42
  B Vindolinine (9)
41
  P 
β-carboline (16)43  M Pseudoindoxylajmalicine (17)44  M 
Apparicine (18)
45
  M N-oxidefluorocarpamine (19)
46
  M 
Mitraphylline (20)
38
  M Rosamine (21)
47
  M 
N,N-dimethyltryptamine (22)
41
  M Nb-acetyltryptamine (23)
40
  M 
Akuammicine (24)
42
  S 12-hydroxyakuammicine (25)
48
  S 
Lochneridine (26)
38
  S Alioline (27)
49
 I 
Coronaridine (28)
50
  I 3-epiajmalicine, (29)
44
  C 
Akuammigine (30)
40
  C Hydroxyindolenineajmalicine, 
(31)
44
  
C 
O-deacetylakuammiline, (32)
51
  C 10-hydroxyldeacetylakuammiline 
(33)
44
  
C 
Strictamine (34)
52
  C 18-hydroxystrictamine, (35)
52
  C 
Akuammine (36)
53
  C Alstonine (37)
40
  C 
Anthirine (38)
54
  C 21-hydroxycyclolochnerine, 
(39)
55
  
C 
Lochnerine (40)
56
  C Pericyclivine (41)
42
  C 
N-oxidelochnerine (42)
37
  C 11-methoxy-N-oxide-lochnerine 
(43)
37
  
C 
N-oxidenormacusine B (44)
37
  C Perivine (45)
38
  C 
N4-formylperivine, (46)
42
  C Pleiocarpamine (47)
54
  C 
Sitsirikine (48)
40
  C Dihydrositsirikine (49)
54
  C 
19,20-cis-16-(R)-isositsirikine 
(50)
55
  
C 19,20-trans-16-(R)-isositsirikine 
(51)
55
  
C 
19,20-trans-16-(S)-isositsirikine 
(52) 
C Yohimbine (53)
41
  C 
Bannucine (54)
57
  P Cathovaline (55)
58
  P 
19-(S)-epimisilinec (56)
59
 P Lochnerinine (57)
38
  P 
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Rosicine (58)
60
  P Minovincinine (59)
61
  P 
Vincadifformine (60)
62
  P 19-hydroxytabersonine (61)
60
  P 
Venalstonine (62)
63
  P Vincoline (63)
64
  P 
Vindolicine (64)
37
  P Vindorosine (65)
50
  P 
19-epivindolinine (66)
65
  P Nb-oxidevindolinine (67)
61
  P 
19-epi-N-oxidevindolinine (68)
61
  P Catharanthamine (69)
66
  B 
Catharine (70)
67
 B 17-deacetoxyleurosine (71)
68
 B 
Leurosinone (72)
69
 B 5’-oxoleurosine (73)70 B 
21’-oxo-leurosine (74)70  B Nb’-oxide-Leurosine (75)
71
 B 
4-deacetoxyvinblastine (76)
68
  B Nb-oxide-leurosidine (77)
72
 B 
Roseadine (78)
71
 B Roseamine (79)
71
 B 
Pseudovinblastinediol (80)
73
 B Deacetylvinblastine (81)  B 
N-demethylvinblastine (82)  B 20-deoxyvinblastine (83)
74
 B 
14’-hydroxyvinblastine (84)73  B 15’-hydroxyvinblastine (85)75 B 
Vindesine (86)
76
 B Vinamidine (87)
73
  B 
3’,4’-anhydrovinblastine (88)77 B Vincathicine (89)78 B 
Vindolicine (90)
67
  B Vingramine (91)
79
  B 
Methylvingramine (92)
79
 B Strictosidine lactam (93)
41
 D 
Vincoside (94)
80
 D N-acetylvincoside (95)
80
 D 
Tubotaiwine (96)
81
  A Vincamine (97)
82
 E 
Vallesiachotamine (98)
41
  V Isovallesiachotamine (99)
81
  V 
Vincarodine (100)
67
  E Cathenamine (101)
83
  C 
Ajmalicine (102)
41
 C 19-epiajmalicine (103)
54
 C 
Serpentine (104)
40
 C Tabersonine (105)
40
 P 
11-methoxytabersonine (106)
67
 P Deacetoxyvindoline  (107)
84
 P 
Deacetylvindoline (108)
67
 P Preakuamicine (109)
85
 S 
Class: A = aspidospermatan, B = bisindole, C = corynanthean, D = vincosan,  
E = eburnan, I = ibogan, M = miscellaneous, P = plumeran, S = strychnan, 
V = vallesiachotaman. 
 
N
H
N
(16)
N
(19)
N
O
H
MeOOC
H
N
H
N
OMeOOC
(20)
N
H
N
O
O
COOMe
(17)
N
H
N
H
(18)  
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HN
N
O
O
MeOOC
H
H
(21)
N
H
N
R2R1
(22) R1=CH3, R2=CH3
(23) R1=H, R2=COCH3
N
H
(24) R1=H
(25) R1=OH
N
H
COOMe
R1
N
H
(26)
N
H
COOMe
OH
N
H
N
H
H
MeOOC
(28)
N
H
(27)
N
MeOOC
O
H
N
H
N
O
MeOOC
H
H
H
3
20
(29) C20=R
(30) C20=S
N
N
O
MeOOC
H
H
H
OH
(31)
N
N
MeOOC R2
(32) R1=H, R2=CH2OH, R3=CH3
(33) R1=OH, R2=CH2OH, R3=CH3
(34) R1=H, R2=H, R3=CH3
(35) R1=H, R2=H, R3=CH2OH
R1
R3
N
N
H
COOMe
HO
(36)
Me
O
N-
N+
O
MeOOC
H
H
(37)
N
H
N
(38)
H
HOH2C
H
20
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(39)
N
H
N
O
OH
H
MeO
N
H
N
H
R2
H
R1
(40) C16=R, R1=OMe, R2=CH2OH
(41) C16=S, R1=H, R2=COOMe
16
N
H
N
(45) R1=H
(46) R1=CHO
MeOOC
H
O
R1
N
H
N
H
HOH2C
R1
(42) R1=OMe
(43) R1=H
O
N
H
N
H
O
H CH2OH
(44)
N
N
H
(47)
MeOOC
N
H
N
H
(48) R1=CHCH2
(49) R1=CH2CH3
OH
MeOOC
H
15
16
R1
N
H
MeOOC
OH
H
H
H
(53)
N
H
N
H
OH
MeOOC
H
15
16
R1
(50) R1=cisCHCH3, C16=R
(51) R1=transCHCH3, C16=R
(52) R1=transCHCH3, C16=S
N
Me
N
OAc
HO
H
COOMe
MeO
(54)
N
Me
N
OAc
H
COOMe
O
(55)
NH
O
H
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N
H
N
R1
COOMe
H
O
(56) R1=(S)-CHOHCH3, R2=H
(57) R1=CH2CH3, R2=OMe
(58) R1=H, R2=H
15
14
R2
N
H
N
COOMe
R1
H
(59) R1=OH
(60) R1=H
N
H
N
H
COOMe
(61)
OH
N
H
N
H
(62)
COOMe
N
H
N
H
(63)
MeOOC O
OH
N
Me
N
OAc
HO
H
COOMe
H
(65)
N
H
N
19
MeOOC
(66)
N
H
N
19
MeOOC
(67) C19=R
(68) C19=S
O
N
H
N
H
(64)
MeOOC
H
O
10-vindolinyl
N
H
N
MeOOC
O
H
10-vindolinyl
N
H
N
O
CHO
MeOOC
(70)
N
Me
N
R1
HO
H
COOMe
MeO
N
H
N
H
O
HMeOOC
(71) R1=H, R2=H
(72) R1=OAc, R2=CH2COCH3
R2
(69)
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10-vindolinyl
N
H
R1
R3 R2
O
HMeOOC
(73) R1=CO, R2=CH2, R3=N
(74) R1=CH2, R2=CO, R3=N
(75) R1=CH2, R2=CH2, R3=N
+-O-
N
H
MeOOC
N+
OH
H
(77)
10-vindolinyl
O-
N
R4
N
HO
H
COOMe
MeO
N
H
N
H
MeOOC
R2
R1
(80) R1=OH, R2=OH, R3=H, R4=Me, R5=H
(81) R1=H, R2=OH, R3=OH, R4=Me, R5=H
(82) R1=H, R2=OH, R3=OAc, R4=H, R5=H
(83) R1=H, R2=H, R3=OAc, R4=Me, R5=OH
(84) R1=H, R2=OH, R3=OAc, R4=Me, R5=H
(85) R1=OH, R2=OH, R3=OAc, R4=Me, R5=H
(86) R1=OH, R2=H, R3=OH, R4=Me, R5=H
R3
R5
N
H
N
H
OH
10-vindolinyl
COOMe
(78)
10-vindolinyl
N
H
MeOOC
N
H
(79)
N
R1
N
OAc
HO
H
COOMe
MeO
N
H
N
H
HMeOOC
R2
OH
(76) R1=Me, R2=OH
10-vindolinyl
N
H
N O
HMeOOC
(87)
CHO
10-vindolinyl
N
N
HMeOOC
(89)
10-vindolinyl
N
H
N
MeOOC
(88)
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N
Me
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HO
H
COOMe
MeO
H
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10-vindolinyl
N
Me
N
HO
H
COOMe
MeO
H
OAc
Me
N
N
HO
H
COOMe
MeO
H
OAc
(90)
R1
N
N
MeOOC H
Me
N
O
COOMe
N
H
H
H
COCH(CH3)2
OMe
OMe
(91) R1=H
(92) R1=Me
N
H
NR2
O
OR1
MeOOC
H
H
(93) C3=R, R1=Lactam, R2=H
(94) C3=S, R1=Glucose, R2=H
(95) C3=S, R1=Glucose, R2=Ac
3
N
H
N
H
(98) E
(99) Z
OMe
CHO
H
OE/Z
(97)
N
N
H
MeOOC
OH
N
N
H
MeOOC
O
OH
(100)
N
H
N
H
(96)
COOMe
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N
H
N
O
H
H
MeOOC
(101)
N
H
N
H
COOMe
N
H
N
O
H
MeOOC
(102)
H
N
H
N
O
H
MeOOC
(103)
H
N-
N+
O
MeOOC
(104)
H
R1
N
Me
N
H
MeO
(105) R1=H
(106) R1=OMe
H
HO
R1
COOMe
(107) R1=H
(108) R1=OMe
N
N
MeOOC
CH2OH
(109)  
2.2 Indole Alkaloids 
The indole system can be visualized as a fusion of a pyrrole ring and a benzene 
ring that give two isomeric benzopyrroles: Indole (110) and isoindole (111). 
N
H
NH
(110) (111)  
 Indole (110) is a crystalline solid with melting point of 52°C and soluble in most 
organic solvents. It is a weak base with delocalized electrons from nitrogen into the 
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aromatic structure and can be reduced upon acid introduction to form salt. However, its 
true salts are unknown.
86  
 
Indole (110) consists of a chromophore that will show characteristic ultraviolet 
spectrum with maxima at 225 nm and 270 nm.
87
 As structural change occur in 
chromophore, the exact energy and intensity of absorption will change. Figure 2.2 
shows the UV spectra of the common indole chromophore (a) and effect of substituent 
to the UV spectrum of indole (b).
88
  
 
  
 
 
 
 
 
 
 
 
 
 
Figure 2.2: (a) UV spectra of some common indole chromophores. (b) UV spectra of 
some common substitution in indole chromophores.
88
 
 Indole alkaloids are derived from tryptophan (112), their amino acid precursor. 
There are two main classes of indole alkaloids, both having the indole moiety from 
tryptophan (112). The first class is the simple indole alkaloids. Simple indole alkaloids 
do not present a structural uniformity, having only the indole nucleus or a direct 
derivative of it as a common feature such as bufotenine (113), gramine (114),  
pscilocybine (115), phytostigmines (116) and harmaline (117).
89
 
(a) (b) 
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 Indole bases of the second class contain two structural elements: tryptophan 
(112) or tryptamine (118) as the indole nucleus and a C9- or C10- monoterpene moiety 
derived from secologanin (119). This class of indole alkaloids is known as 
monoterpenoid indole alkaloid.  
 
2.3 Biosynthesis of the Monoterpenoid Indole Alkaloids from Catharanthus roseus 
 Every metabolite in green plant is the product of photosynthesis, either directly 
or indirectly. Therefore, biosynthesis of indole alkaloids also starts from sugar 
production through photosynthesis. Sugar that is produced will serve as the substrate for 
glycolysis. In glycolysis sugar will be broken into smaller organic molecules to supply 
both energy by releasing chemical energy and material for biosynthesis of indole 
alkaloids (Figure 2.3).
90
 
N
H
HO
CH2CH2N(CH3)2
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Part of the energy is used while some are stored with conversion of enzymatic 
cofactors to their more energetic state such as reduced nicotinamide-adenine 
dinucleotide phosphate (NADPH) and adenosine triphosphate (ATP). NADPH is a 
strong reducing agent and carrier of chemical potential. ATP is the carrier of chemical 
potential and a powerful phosphorylating agent.
89
  
Sugar such as glucose is broken down into phosphoenol pyruvate (120) and 
erythrose-4-phosphate (121) through glycolysis. Phosphoenol pyruvate (120) and 
erythrose-4-phosphate (121) both are used in the production of indole alkaloid 
precursor, tryptophan (112) through shikimate (122) and chorismate (123) biosynthesis 
(Figure 2.3 & 2.4).
91
 Tryptophan (112) can only be synthesized by bacteria and green 
plants. Most indole alkaloids are derived from tryptamine (118), the decarboxylation 
product of tryptophan (112) (Figure 2.3).  
 Phosphoenol pyruvate (120) is further reduced into pyruvate (124). The 
terpenoids moiety in monoterpenoid indole alkaloids was produced by triose 
phosphate/pyruvate or “non-mevalonate” pathway.92 The respective triose phosphate, 
glyceraldehyde-3-phosphate (125) was firstly produced in the Calvin cycle of 
photosynthesis.
93
 It was used together with pyruvate (124) produce 1-deoxy-D-
xylulose-5-phosphate (126) that is the precursor involve in formation of isopentenyl 
pyrophosphate (127), the precursor of all terpenoids.
94; 95
 Secolaganin (119) is derived 
from “non-mevalonate” pathway by way of isopentenyl pyrophosphate (127) and 
geraniol (128) (Figure 2.5).
95
  
 The biosynthesis of monoterpenoid indole alkaloids starts by the  stereoselective 
condensation of tryptamine (118) with secologanin (119) to isovincoside, also known as 
strictosidine (129) (Figure 2.3).
89
 Strictosidine (129) is futher biosynthesize to 
dehydrogeissoschizine (130) that will serve as the intermediate for formation of 
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corynanthean, strychnan, ibogan and plumeran type of monoterpenoid indole alkaloids. 
(Figure 2.3 & 2.6) 
 Dehydrogeissoschizine (130) is the central intermediate for biosynthesis of 
corynanthean indole alkaloids. Cathenamine (101) is the major product from 
deglycosylation of strictosidine (129). Reduction of cathenamine (101) intermediate 
will give other corynanthean indole alkaloids such as tetrahydroalstonine (5), ajmalicine 
(102) and 19-epi-ajmalicine (103). Ajmalicine (102) is converted into serpentine (104) 
in plant by the present peroxidase enzyme. (Figure 2.7) 
 The more complex plumeran, ibogan and strychnan alkaloids are derivatives of 
corynanthean. Strictosidine derivative, preakuammicine (109) is the common precursor 
for plumeran, ibogan and strychnan alkaloids. Preakuammicine (109) is from 
geissochizine (131) but the actual mechanism and physiological precursor for 
preakuamicine (109) remains unknown.
95
 
 Preakuamicine (109) is reduced to form stemmadenine (132) that is rapidly 
consumed for rearrangement to form the acrylic ester dehydrosecodine (133) which 
serves as common intermediate for plumeran and ibogan skeletons. Tabersonine (105), 
plumeran type alkaloid is formed from a Diels-Alder reaction(Figure 2.8).
95
 In our 
study, we obtained monoterpenoid indole alkaloids of corynanthean and plumeran from 
the leaves of Catharanthus roseus (Figure 2.8). 
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Figure 2.3: Biosynthesis of monoterpene indole alkaloids in  
Catharanthus roseus.
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Figure 2.4: Biosynthesis of tryptophan (112).
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Figure 2.6: Formation of dehydrogeissoschizine (130) from strictosidine (129).
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Figure 2.7: Corynanthean biosynthesis from dehydrogeissoschizine (130).
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Figure 2.8: Proposed biosynthetic pathway of plumeran and ibogan alkaloids.
95
 
  
The major indole alkaloid that was obtained in our study, vindoline (4) was 
biosynthesize from tabersonine (105). Firstly, tabersonine (105) was hydroxylated to 
11-hydroxytabersonine (134) followed by O-methylation to 11-methoxytabersonine 
(106). Next step was hydration of a double bond to produce 11-methoxy-2,16-dihydro-
16-hydroxytabersonine (135) followed by transfer of methyl to indole nitrogen to yield 
deacetoxyvindoline (107). Introduction of O-acetyl moiety at C-16 was achieved by 
hydroxylation to yield deacetylvindoline (108) and acetylation to yield vindoline (4) 
(Figure 2.9). 
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Figure 2.9: Vindoline (4) biosynthesis from tabersonine (105).
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3.1 Alkaloids isolated from Catharanthus roseus 
 The leaves of Catharanthus roseus (L.) G. Don. were studied for their indole 
alkaloids. Firstly, the leaves were de-fatted using hexane followed by general 
dichloromethane extraction procedure to obtain 44.5 g crude with 4.45 % yield.  Next, 
the crude extract was subjected to acid-base extraction obtaining 6.0 g of alkaloid crude. 
Finally, fractionation and extensive chromatography of the alkaloid crude extract 
yielded seven indole alkaloids, namely: vindoline (4), vindolinine (9), perivine (45), 
vindorosine (65), vindolicine (90), serpentine (104) and vindogentianine (136). The 
following sub-chapters will discuss briefly the structural elucidation of each alkaloid. 
3.2 Alkaloid I: Vindoline (4) 
N
Me
N
OCOMeH
COOMeHO
H
MeO 11 21
22
14
15
18
16
17
12 13
2
10 9
6
5
3
19
8
7
20
(4)  
Alkaloid I,     
   -46° (c 1.0, MeOH) was isolated as yellowish brown 
amorphous solid. Its’ ESIMS spectrum showed a pseudomolecular ion peak at m/z 457 
(M+H)
+
 and the molecular formula C25H32N2O6 was established by ESI-TOFMS [m/z 
457.2390 (M+H)
+, Δ +5.5 mmu]. IR absorptions implied the presence of hydroxyl 
(3458 cm
-1
) and ester carbonyl (1741 cm
-1
) functionalities.
97
 Alkaloid I showed UV 
absorption of      
           : 224 (5.00), 251 (4.79) and 307 (4.63) nm suggests a 
dihydroindole moiety
98
. 
The 
13
C spectrum showed the presence of 25 carbons; three sp
3
 methines, four 
sp
3
 methylenes, five methyls, five sp
2
 methines and eight carbonyl carbons. The 
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presence of an ester functionality was supported by the observed quaternary carbon 
signal at δC 171.9 (C-22) and the corresponding methyl resonance at δC 52.2 (22-OMe). 
The presence of an acetate functionality was indicated by the resonance at δC 170.8 with 
the corresponding methyl resonance at δC 21.1. Two downfield signals at δC 76.4 and δC 
79.6 were due to oxygenated quaternary C-16 and oxymethine C-17 carbons 
respectively. Two aminomethylene carbons; C-5 and C-3 resonated at δC 51.9 and δC 
51.1 while aminomethine C-21 resonated at δC  67.0. 
The 
1
H NMR spectrum of alkaloid I showed the presence of two strong methoxy 
singlets at δH 3.73 and δH 3.72 that belong to 22-OMe and 11-OMe respectively. Two 
strong singlets at δH 2.62 and δH 2.02 revealed the presence of N-methyl and acetyl 
respectively. Three singlets of two aminomethine (H-21 & H-2) and a methine (H-17) 
appeared at δH 2.61, δH 3.69 and δH 5.45 respectively. Three aromatic protons H-12, H-
10 and H-9 resonated at δH 6.01, δH 6.28, δH 2.83 as doublet (J = 2.3 Hz), doublet of 
doublets (J = 2.3, 8.2 Hz) and doublet (J = 8.2 Hz) respectively. The observed splitting 
pattern suggested that C-11 is substituted. Two olefinic cis proton signals appeared at δH 
5.18 (1H, d, J = 10.6 Hz, H-15) and δH 5.79 (1H, ddd, J = 1.8, 5.0, 10.6 Hz, H-14).  
Table 3.1: 
1
H and 
13
C-NMR Data for Alkaloid I compared with the literature of 
vindoline (4).99-101 
Position 
Alkaloid I Vindoline (4) 
δH δC δH δC 
2 3.69 (s, 1H) 83.4 3.75 83.2 
3 
3.44 (α, ddd, 1Ha, J = 1.7, 5.0, 16.5 Hz) 
2.77 (β, dt, 1Hb, J = 1.7, 16.5 Hz) 
51.1 3.40 50.9 
5 
3.36 (α, ddd, 1Ha, J = 4.6, 8.5, 14.2 Hz) 
2.47 (β, dt, 1Hb, J = 8.5, 10.1 Hz) 
51.9 
2.1-3.0 
51.9 
6 2.25 (m, 2H) 44.1 43.9 
7 - 52.8 - 52.6 
8 - 125.0 - 124.9 
9 6.83 (d, 1H, J = 8.2 Hz) 122.7 6.91 122.4 
10 6.24 (dd, 1H, J = 2.3, 8.2 Hz) 104.6 6.30 104.5 
11 - 161.1 - 161.1 
12 6.01 (d, 1H, J= 2.3 Hz) 95.8 6.08 95.6 
13 - 153.7 - 153.6 
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14 5.79 (ddd, 1H, J = 1.7, 5.0,10.6 Hz) 124.1 5.88 123.9 
15 5.18 (br-d, 1H, J=10.6 Hz) 130.5 5.23 130.2 
16 - 79.6 - 79.5 
17 5.40 (α, s, 1Ha) 76.4 5.43 76.2 
18 0.43 (t, 3H, J = 7.3 Hz) 7.7 0.48 7.5 
19 
1.58 (α, q, 1Ha, J = 7.3 Hz) 
1.07 (β, q, 1Hb, J = 7.3 Hz) 
30.8 1.35 30.6 
20 - 42.9 - 42.8 
21 2.61 (s, 1H) 67.0 2.65 67.0 
22 - 171.9 - 171.1 
OCOMe - 170.8 - 170.4 
COMe 2.02 (s, 3H) 21.1 2.07 20.8 
NMe 2.62 (s, 3H) 38.3 2.68 38.0 
11-OMe 3.73 (s, 3H) 55.3 3.80 55.1 
22-OMe 3.72 (s, 3H) 52.2 3.80 51.9 
OH 9.55 - 9.00 - 
 
The 
1
H-
13
C HMBC cross-peaks of H-3 to C-5 and C-21 together with H-5 to C-3 
and C-21 established the connectivities of H-3, H-5 and H-21 through a sp
3
 nitrogen. 
1
H-
13
C HMBC cross-peaks of H-15 to C-3 established the presence of olefenic moiety 
in ring D system. H-18 to C-20 correlation of 
1
H-
13
C HMBC suggested the connectivity 
of ethyl to ring C and D. 
1
H-
13
C HMBC correlation of H-17 to C-16 and H-2 to C-16 
established the ring system C. The 
1
H-
13
C HMBC correlation of protons from different 
ring system such as H-5, H-3, H-17, H-2 to C-21 and H-21 to C-8 established the 
connection of ring system A-E as vindoline (4). The correlation for protons of 11-OMe 
to C-11 indicated that C-11 was substituted. N-methyl presence in the indole system 
was confirmed through correlation of H-NMe to C-13 and H-2 to C-NMe. The 
connectivity of acetyl moiety to C-17 in ring C was confirmed through the correlation 
observed between H-17 and C-OCOMe.  
Finally thorough analysis of 1D and 2D NMR (COSY, HMQC and 
1
H-
13
C 
HMBC) with coupled with comparison literature values.
99-101
 It was confirmed the 
identity of alkaloid I as the known plumeran indole alkaloid, vindoline (4). 
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Figure 3.1: Selected 
1
H-
13
C HMBC correlation of alkaloid I. 
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3.3 Alkaloid II: Vindolinine (9) 
N
H
N
H
11
10 9
12 13
8 7
2
6
5
3
14
1520
21
18
19
MeOOC
16
17
22
(9)  
 Alkaloid II,     
    -46° (c 1.0, MeOH) was obtained as yellowish brown 
amorphous solid. The ESIMS spectrum showed a pseudomolecular ion peak at m/z 337 
(M+H)
+
 and the molecular formula C21H24N2O4 was established by ESI-TOFMS [m/z 
337.1940 (M+H)
+, Δ +2.8 mmu]. IR absorptions implied the presence of amine (3365 
and 1246 cm
-1
), ester carbonyl (1725 cm
-1
) and aromatic (1466 cm
-1
) functionalities.
97
 
Alkaloid II showed UV absorption of      
           : 216 (4.14), 244 (3.95), 295 (3.77) 
and 308 (3.71) nm revealed the presence of typical dihydroindole moiety.
98
 
Analysis of the 
1
H and 
13
C NMR data (Table 3.2) and the HMQC spectrum of 
alkaloid II revealed the presence of three sp
3
 methine, four sp
3
 methylene, two methyl, 
six sp
2
 methine and six quaternary carbons. The presence of an ester functionality was 
supported by the observed quaternary signal at δC 174.6 (C-22) and the corresponding 
methyl resonance at δC 52.3 (22-OMe). Two aminomethylene carbons of C-5 and C-3 
resonated at δC 58.1 and δC 50.1 respectively. The aminomethine (C-21) resonated at δC 
77.4. 
The 
1
H-NMR spectrum of alkaloid II showed one strong methoxyl singlet at δH 
3.69 that belongs to 22-OMe. One singlet most probably belongs to the aminomethine 
H-21, was observed at δH 3.49. Four aromatic protons H-9, H-10, H-11 and H-12 
resonated at δH 7.30, δH 6.84, δH 7.05 and δH 6.76 as doublet (J=6.7 Hz), ddd (J=1.2, 
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6.7, 7.4 Hz), ddd (J=1.2, 7.4, 8.0 Hz) and a doublet (J=8.0 Hz) respectively, thus, 
suggesting an unsubstituted indole system.  A doublet (J=6.7 Hz) representing a methyl 
protons was observed at δH 0.94 (H-18). Two olefinic cis proton signals appeared at δH 
6.15 (1H, dd, J = 3.6, 9.8 Hz, H-15) and δH 5.75 (1H, ddd, J = 1.8, 4.9, 9.8 Hz, H-14).  
Table 3.2: 
1
H and 
13
C-NMR Data for Alkaloid II compared with  
literature of vindolinine (9).
102
 
Position 
Alkaloid II Vindolinine (9)
102
 
δH δC δH 
2 - 81.6 - 
3 
4.00 (dd, 1H, J=4.6, 17.7 Hz) 
3.46 (m, 1H overlapped with H5 & 
H21) 
50.1 
3.97 (dd, 18 & 5 Hz) 
3.45 (ddd, 2, 3.3& 18 Hz) 
5 
3.40 (m, 1H overlapped with H3 & 
H21) 
3.30 (m, 1H) 
58.1 
3.40 (dd, 8 & 9 Hz) 
3.29 (ddd, 7, 9 & 10.5 Hz) 
6 
2.15 (m, 1H) 
1.87 (m, 1H overlapped with H17) 
36.2 
2.17 (dd, 7 & 16 Hz) 
1.85 (ddd, 9, 10.5 &  
16 Hz) 
7 - 60.1 - 
8 - 139.2 - 
9 7.30 (d, 1H, J=6.7 Hz) 124.3 
6.7-7.4 
10 6.84 (ddd, 1H, J=1.2, 6.7, 7.4 Hz) 121.6 
11 7.05 (ddd, 1H, J=1.2, 7.4, 8.0 Hz) 127.7 
12 6.76 (d, 1H, J=8.0 Hz) 112.9 
13 - 149.5  
14 5.75 (ddd, 1H, J=1.8, 4.6, 9.8 Hz) 128.0 5,78 (ddd, 2, 5 & 10 Hz) 
15 6.15 (dd, 1H, J=3.6, 9.8 Hz) 131.2 6.16 (dd, 3.3 & 10 Hz) 
16 3.04 (dd, 1H, J=6.1, 12.2 Hz) 39.4 3.04 (dd, 6 & 12 Hz) 
17 
2.45 (ddd, 1H, J=1.8, 6.1, 14.6 Hz) 
1.80 (m, 1H, overlapped with H6) 
29.2 
2.47 (dd, 6 & 14.5 Hz) 
1.80 (dd, 12 & 14.5 Hz) 
18 0.94 (d, 3H, J=6.7 Hz) 7.6 0.96 (d, 7 Hz) 
19 2.07 (dd, 1H, J=1.2, 6.7 Hz) 48.8 2.08 (q, 7 Hz) 
20 - 46.1 - 
21 3.49 (s, 1H) 77.4 3.46 (s) 
22 - 174.6  
22-OMe 3.69 (s, 3H) 52.3 3.70 (s) 
 
The structure of alkaloid II was deduced from analyses of the 2D NMR data, 
including COSY, HMQC and 
1
H-
13
C HMBC spectra in chloroform-d (Figure 3.21). The 
COSY and HMQC spectra revealed connectivities of five partial structures a-e; a (H-9 
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to H-12), b (H-5 to H-6), c (H-3 to H-15), d (H-16 to H-17) and e (H-19 to H-20) 
(Figure 3.7). 
The 
1
H-
13
C HMBC cross-peaks of H-12 to C-8, H-6 to C-8 revealed the 
connectivity of partial structure a with b and the attachment of partial structure b to the 
indole moiety,  while the 
1
H-
13
C HMBC cross-peaks of H-21 to C-6, C-8 and C-17 
revealed the connectivity of partial structure a, b, d. The 
1
H-
13
C HMBC cross-peak of 
H-5 to C-3 is a direct connection of partial structure b with c, while cross-peaks of H-
15, H-17, H-18 to C-20 revealed the connection of c, d, e.  The 
1
H-
13
C HMBC cross-
peaks of H-16 to C-2, C-22, H-18 to C-22 and 22-OMe protons to C-22 revealed the 
attchement of partial structure d and e with indole moiety and connectivity of the 
methoxy carboxylate with partial structure d. Thus the structure of alkaloid II was 
assigned as shown in Figure 3.7. 
N
H
N
H
9
12 13
8
7
2
6
5
3
14
15
20
19
MeOOC
16
17
22
1H-13C HMBC
a
b
c
d
e
COSY
(9)  
Figure 3.7: COSY and selected 
1
H-
13
C HMBC correlation of alkaloid II 
  
 Therefore, the COSY and 
1
H-
13
C HMBC correlation as shown in Figure 3.7 
together with comparison of 
1
H data of the literature value
102
 confirmed the identity of 
alkaloid II as the known plumeran indole alkaloid, vindolinine (9).  
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3.4 Alkaloid III: Perivine (45) 
N
H
HN
O
MeOOC
H
16
18
19
20
15
6
5
3 21
7
2
14
8
910
11
12
13
22
(45)
H
H
 
 Alkaloid III,     
   -76° (c 1.0, MeOH) obtained as yellowish brown amorphous 
solid. The ESIMS showed a pseudomolecular ion peak at m/z 339 (M+H)
+
 and the 
molecular formula C20H22N2O3 was established by ESI-TOFMS [m/z 339.1690 (M+H)
+
, 
Δ -1.7 mmu]. The IR absorptions implied the presence of amine (3311 and 1643 cm-1) 
and ester carbonyl (1725 cm
-1
) functionalities.
97
 Alkaloid III showed UV absorption of  
    
           : 228 (4.36), 296 (4.11) and 314 (4.29) nm. 
Analysis of the 
1
H and 
13
C NMR data (Table 3.3) and the HMQC spectrum of 
alkaloid III revealed the presence of three sp
3
 methine, three sp
3
 methylene, two methyl, 
five sp
2
 methine and seven quaternary carbons. The presence of an ester functionality 
was supported by the observed quaternary signal at δC 171.2 (C-22) and the 
corresponding methoxy resonance at δC 50.7 (22-OMe). A quaternary ketone carbon 
signal that resonated at δC 190.5 (C-3) was also observed. Two downfield signals of an 
aminomethine C-5 and aminomethylene C-21 carbons were found resonated at δC 51.0 
and δC 25.7 respectively. Two signals for olefinic quaternary C-20 and methine C-19 
carbons were observed at δC 137.8 and δC 120.4 respectively. 
1
H-NMR spectrum of alkaloid III revealed the presence of one methoxy signal 
for 22-OMe at δH 2.62, a doublet signal of methyl for H-18 at δH 1.67 and an olefinic 
proton H-19 signal at δH 5.41. It also revealed an unsubstituted aromatic indole system 
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with the presence of four aromatic proton signals at δH 7.13 (H-10), δH 7.32 (H-11 & H-
12) and δH 7.70 (H-9). 
The structure of alkaloid III was deduced from analyses of the 2D NMR data, 
including COSY, HMQC and 
1
H-
13
C HMBC spectra in methanol-d4 (Figure 3.13). The 
COSY and HMQC spectra revealed connectivities of three partial structures a-c; a (H-9 
to H-10), b (H-6 to H-14) and c (H-19 to H-18) (Figure 3.13). 
The 
1
H-
13
C HMBC cross-peaks of H-9 to C-7, H-6 to C-8 and H-14 to C-2 
revealed the connectivity of partial structure a with b and the attachment of partial 
structure b to the indole moiety, while the 
1
H-
13
C HMBC cross-peaks of H-19 to C-15 
and C-21 revealed the connectivity of partial structure b, c and the connection of 
isolated aminomethylene to partial structure c. In addition, the 
1
H-
13
C HMBC cross-
peak of H-21 to C-5 established the connection of the isolated aminomethylene with 
partial structure b. The presence of a methyl carboxylate moiety at C-16 and carboxylate 
moiety at C-3 were analysed by 
1
H-
13
C HMBC correlation as shown in Figure 3.13. 
Table 3.3: 
1
H and 
13
C-NMR Data for Alkaloid III with comparison of the literature 
13
C 
value of Vobasine
103
. 
Position 
Alkaloid III Vobasine 
δH δC δC 
2 - 134.3 134.0 
3 - 190.5 190.2 
5 4.14 (br-s, 1H, overlapped with H21) 51.0 57.2 
6 
3.63 (m, 1H) 
3.50 (m, 1H) 
25.7 20.3 
7 - 120.4 120.3 
8 - 128.6 128.4 
9 7.70 (d, 1H J=8.2 Hz) 121.2 120.8 
10 7.13 (br-s, 1H) 120.7 120.3 
11 
7.32 (br-s, 2H) 
127.0 126.6 
12 112.0 111.8 
13 - 136.6 136.4 
14 
3.34 (t, 1H, J=13.3 Hz) 
2.74 (dd, 1H, J=7.3, 13.3 Hz) 
43.4 43.0 
15 3.82 (m, 1H) 31.3 30.4 
16 2.65 (overlapped with 22-OMe) 49.6 46.7 
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18 1.67 (d, 3H, J=6.7 Hz) 12.4 12.3 
19 5.41 (br-q, 1H, J=6.7 Hz) 120.4 120.8 
20 - 137.8 135.8 
21 
4.11 (d, 1H, overlapped with H5) 
3.23 (d, 1H, J=15.1 Hz) 
43.8 51.8 
22 - 171.2 171.2 
22-OMe 2.62 (s, 3H, overlapped with H16) 50.7 50.4 
N(1)H 9.12, br-s - - 
N(4)H/Me 8.76, br-s - 42.3 
 
N
H
N
O
MeOOC
H
16
18
19
20
15
6
5
3 21
7
2
14
8
910
11
12
13
22
Me
Vobasine  
 
N
H
HN
O
MeOOC
H
16
19
15
6
5
3
21
7
2
14
8
910
11
12 13
22
18
1H-13C HMBC
a
b
c
COSY
(45)  
Figure 3.13: COSY and selected 
1
H-
13
C HMBC correlation of alkaloid III. 
  
 Therefore, the COSY and 
1
H-
13
C HMBC correlation as shown in Figure 3.13 
together with comparison of 
13
C data literature value of vobasine
103
 confirmed the 
identity of alkaloid III as the known corynanthean indole alkaloid, perivine (45).  
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3.5 Alkaloid IV: Vindorosine (65) 
N
Me
N
OCOMeH
COOMeHO
H
11 21
22
14
15
18
16
17
12 13
2
10 9
6
5
3
19
8
7
20
(65)  
 Alkaloid IV isolated as yellowish brown amorphous solid. The ESIMS showed a 
pseudomolecular ion peak at m/z 427 (M+H)
+
 and the molecular formula C24H30N2O5 
was established by ESI-TOFMS [m/z 427.2290 (M+H)
+, Δ +5.5 mmu]. Alkaloid IV 
showed difference of 30 m/z in mass as compared to vindoline (4). Thus, suggesting 
alkaloid IV as derivative of vindoline (4) lacking of a methoxy functionality. IR 
absorptions implied the presence of hydroxyl (3422 cm
-1
) and ester carbonyl ester (1741 
cm
-1
) functionalities.
97
 Alkaloid IV showed UV absorption of      
           : 203 
(4.16), 252 (3.83) and 308 (3.50) nm suggests a dihydroindole moiety.
98
  
 The 
13
C NMR data of alkaloid IV revealed the presence of three sp
3
 methine, 
four sp
3
 methylene, four methyl, six sp
2
 methine and seven quaternary carbons. The 
1
H 
and 
13
C NMR data of alkaloid IV show close similarity with vindoline (4) as shown in 
Table 3.4. The significant difference is the addition of an aromatic proton (δH11 7.12, t, 
1H, J = 7.7 Hz) with the disappearance of 11-OMe signals as compared to those of 
vindoline (4) in 
1
H NMR spectrum. Therefore, C-11 is not substituted. The downfield 
shift of C-8 (δC 133.1), C-10 (δC 119.3), C-12 (δC 109.6) and upfield shift of C-11 (δC 
129.0) were observed as compared to those of vindoline (4) in the 
13
C NMR spectrum.  
 Alkaloid IV identity was confirmed as known plumeran indole alkaloid, 
vindorosine (65), through detail analysis of 2D NMR data, including COSY, HMQC 
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and 
1
H-
13
C HMBC spectra with comparison of 
1
H and 
13
C data of vindoline (4) 
literature value.99; 100  
Table 3.4: 
1
H & 
13
C NMR Data for Alkaloid IV compared with literature  
 of vindoline (4). 99; 100 
Position 
Alkaloid IV Vindoline (4) 
δH δC δH δC 
2 3.71 (s, 1H) 82.9 3.75 83.2 
3 
3.49 (α, dd, 1Ha, J = 4.1, 16.3 Hz) 
2.81 (β, d, 1Hb, J = 16.3 Hz) 
51.2 3.40 50.9 
5 
3.41 (α, m, 1Ha) 
2.52 (β, m, 1Hb) 
52.4 
2.1-3.0 
51.9 
6 2.36 (m, 2H) 44.3 43.9 
7 - 52.4 - 52.6 
8 - 133.1 - 124.9 
9 7.00 (d, 1H, J = 7.7 Hz) 122.4 6.91 122.4 
10 6.74 (t, 1H, J = 7.7 Hz) 119.3 6.30 104.5 
11 7.12 (t, 1H, J = 7.7 Hz) 129.0 - 161.1 
12 6.50 (d, 1H, J = 7.7 Hz) 109.6 6.08 95.6 
13 - 152.6 - 153.6 
14 5.81(dd, 1H, J =  4.1, 10.4 Hz) 124.1 5.88 123.9 
15 5.20 (d, 1H, J = 10.4 Hz) 130.4 5.23 130.2 
16 - 79.6 - 79.5 
17 5.45 (α, s, 1Ha) 76.5 5.43 76.2 
18 0.43 (t, 3H, J = 7.3 Hz) 7.7 0.48 7.5 
19 
1.61 (α, q, 1Ha, J = 7.3) 
1.05 (β, q, 1Hb, J = 7.3) 
30.9 1.35 30.6 
20 - 43.1 - 42.8 
21 2.65 (s, 1H) 67.4 2.65 67.0 
22 - 172.0 - 171.1 
OCOMe - 170.9 - 170.4 
COMe 2.05 (s, 3H) 21.2 2.07 20.8 
NMe 2.66 (s, 3H) 38.6 2.68 38.0 
11-OMe - - 3.80 55.1 
22-OMe 3.77 (s, 3H) 52.4 3.80 51.9 
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3.5 Alkaloid V: Vindolicine (90) 
N1
Me
N
OCOMeH
COOMeHO
H
MeO 11 21
22
14
15
18
16
17
12 13
2
10 9
6
5
3
19
8
7
20
(90)
Me
N1'
N
OCOMeH
COOMeHO
H
MeO
11'
21'
22'
14'
15'
18'
16'
17'
12' 13'
2'
10' 9'
6'
5' 3'
19'
8'
7'
20
23'
23
H2C
 
Alkaloid V,     
    -75° (c 1.0, MeOH) was obtained as yellowish brown 
amorphous solid. The ESIMS showed a pseudomolecular ion peak at m/z 925 (M+H)
+
 
and the molecular formula C51H64N4O12 was established by ESI-TOFMS [m/z 925.4665 
(M+H)
+, Δ +6.6 mmu]. The large mass value indicated the dimeric nature of alkaloid V. 
The ESIMS spectrum also revealed the presence of (M/2+H)
+
 fragment ion peak (m/z 
463) which implied that alkaloid V to be a dimer consists of the same monomer.  
IR absorptions implied the presence of hydroxyl (3432 cm
-1
) and carbonyl ester 
(1741 cm
-1
) functionalities.
97
 Alkaloid V showed UV absorption of      
          : 217 
(4.61), 253 (4.37) and 308 (4.03) nm reveal the presence of dihydroindole moiety.
98
  
 Analysis of the 
1
H and 
13
C NMR data (Table 3.5) and the HMQC spectrum of 
alkaloid V revealed the presence of three sp
3
 methine, five sp
3
 methylene, five methyl, 
four sp
2
 methine and nine quaternary carbons. The 
1
H and 
13
C NMR spectra of alkaloid 
V were very similar to those of vindoline (4) except the addition of a methylene group 
(δH 1.21, s; δC 29.82) and loss of proton signal of H-10/H-10’. The 
1
H-NMR spectrum of 
alkaloid V revealed presence of four aromatic singlets for H-9, 9’ and H-12, 12’ at δH 
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6.74 and δH 6.01 respectively, thus suggesting that these protons are situated para to 
each other. Therefore, indicating that C-11/C-11’ and C-10/C-10’ are substituted.  
Table 3.5: 
1
H and 
13
C-NMR Data for Alkaloid V with comparison with 
13
C-NMR data 
of literature vindolicine (90).
71
 
Position 
Alkaloid V Vindolicine (90) 
δH δC δC δC’ 
2, 2’ 3.62 (s, 1H) 83.7 83.0 
3, 3’ 
3.44 (dd, 1H, J=4.5, 16.3 Hz) 
2.73 (d, 1H, J=16.3 Hz) 
51.2 50.9 51.0 
5, 5’ 
3.35 (ddd, 1H, J=3.6, 8.4 Hz) 
2.40 (d, 1H, J=8.4 Hz) 
52.4 50.8 50.6 
6, 6’ 2.25 (m, 2H) 43.9 42.7 41.5 
7, 7’ - 53.1 52.7 52.8 
8, 8’ - 123.8 123.4 
9, 9’ 6.74 (s, 1H) 124.0 123.7 124.1 
10, 10’ - 121.1 124.4 
11, 11’ - 158.6 159.0 
12, 12’ 6.01 (s, 1H) 93.6 93.5 93.0 
13, 13’ - 151.9 152.1 
14, 14’ 5.78 (dd, 1H, J=4.5, 10.3 Hz) 124.2 123.9 124.4 
15, 15’ 5.15 (d, 1H, J=10.3 Hz) 130.7 130.2 130.0 
16, 16’ - 79.7 79.3 79.5 
17, 17’ 5.41 (s, 1H) 76.5 75.9 76.0 
18, 18’ 0.31 (t, 3H, J=7.3 Hz) 7.9 7.1 7.1 
19, 19’ 
1.54 (q, 1H, J=7.3 Hz) 
1.00 (q, 1H, J=7.3 Hz) 
31.0 30.5 30.3 
20, 20’ - 43.1 42.5 42.4 
21, 21’ 2.49 (s, 1H) 67.3 67.0 
22, 22’ - 172.2 170.6 
23, 23’-Me 2.02 (s, 3H) 21.2 20.7 
N1/N1’-Me 2.60 (s, 3H) 39.1 38.0 37.7 
11, 11’-OMe/’ 
3.74 (s, 6H) 
55.5 55.1 
22, 22’-OMe/’ 52.4 52.0 51.8 
23, 23’ - 170.9 171.6 171.4 
CH2 1.21 (s, 2H) 29.8 34.0 
 
The structure of alkaloid V was deduced to consist of two vindoline (4) unit that 
form a methylene bridge at C-10/C-10’ to be a symmetrical dimer. The HMBC 
spectrum showed correlation signal between CH2 with H-9/H-9’ and C-11/C11’. Thus, 
signifying that both monomers are connects through CH2. The 
1
H-
13
C HMBC cross-
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peak of H-9/H-9’ to CH2 established the connection for each vindoline (4) monomer 
through a methylene bridge.  
N1
Me
N
OCOMe
MeO
H
HO COOMe
H
11
9
13
7
CH2
10-vindolinyl
1H-13C HMBC
(90)  
Figure 3.21: Selected 
1
H-
13
C HMBC correlation of alkaloid V. 
 
  
Finally, thorough analysis of 2D NMR that includes HMQC, COSY and 
1
H-
13
C 
HMBC together with comparison of the 
13
C literature values confirmed the identity of 
alkaloid V as the known plumeran bisindole alkaloid, vindolicine (90).  
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3.7 Alkaloid VI: Serpentine (104) 
N-
N+
O
H
MeOOC
11
12 13
8
10 9
7
2
3
14 15
16
17
22
20
19 18
21
5
6
(104)
H
 
 Alkaloid VI,     
   +60° (c 1.0, MeOH) obtained as yellowish brown amorphous 
solid. ESIMS spectrum showed a pseudomolecular ion peak at m/z 349 (M+H)
+
 and the 
molecular formula C21H20N2O3 was established by ESI-TOFMS [m/z 349.1560 (M+H)
+
, 
Δ +0.6 mmu]. Alkaloid VI showed UV absorption of      
           : 251 (4.20), 308 
(4.02) and 363 (3.58) nm. 
Analysis of the 
1
H and 
13
C NMR data (Table 3.6) and the HMQC spectrum of 
alkaloid VI revealed the presence of three sp
3
 methine, two sp
3
 methylene, two methyl, 
seven sp
2
 methine and seven quaternary carbons. The presence of an ester functionality 
was supported by the observed quaternary signal for C-22 at δC 168.8 and the 
corresponding oxygenanted methyl resonance at δC 51.8. Two highly downfield carbon 
signals at δC 156.4 and δC 107.2 were belong to an oxygenated methine C-17 and 
quaternary carbons C-16 of an olefin system respectively. Another two signals for an 
aromatic aminomethine C-5 and amino-quaternary C-3 carbons were observed at δC 
134.3 and δC 141.3 respectively. 
1
H NMR spectrum of alkaloid VI showed the presence of six aromatic protons 
signal at δH 7.43 (H-10), δH 7.72-7.78 (H-11 & H-12), δH 8.33 (H-5 & H-9) and δH 8.47 
(H-6). An oxygenated olefinic proton  H-17 signal at δH 7.70 and a methoxy group 
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associated with a methyl ester function as singlet at δH 3.77 (22-OMe), A characteristic 
methyl protons,  H-18 that appear as a doublet at δH 1.33 (J=6.6 Hz) was also observed.          
Table 3.6: 
1
H and 
13
C-NMR Data for Alkaloid VI compared with the literature of 
Serpentine (104)
104
. 
Position 
Alkaloid VI Serpentine (104) 
δH δC δH δC 
2 - 135.8 - 135.8 
3 - 141.3 - 141.2 
5 8.33 (overlapped with H9) 134.3 8.31 (d, J=6.6 Hz) 134.2 
6 8.47 (d, 1H, J=6.1 Hz) 116.8 8.46 (d, J=6.6 Hz) 116.8 
7 - 132.6 - 132.6 
8 - 121.4 - 121.3 
9 8.33 (overlapped with H5) 124.1 8.31 (dd, J=1.0, 8.1 Hz) 124.0 
10 7.43 (t, 1H, J=7.1 Hz) 123.2 7.43 (ddd, J=1.3, 6.6, 8.1 Hz) 123.2 
11 
7.72-7.78 (br-s, 2H) 
132.9 
7.76 (ddd, J= 1.0, 6.6, 8.4 
Hz) 
132.9 
12 114.0 7.72 (dd, J=1.3, 8.4 Hz) 113.9 
13 - 145.4 - 145.4 
14 
4.68 (dd, 1H, J= 4.9, 18.2 
Hz) 
3.15 (dd, 1H, J=11.5, 18.2 
Hz) 
31.9 
4.64 (α, dd, J=4.7, 18.1 Hz)  
3.13 (β, dd, J=11.6, 18.1 Hz) 
31.9 
15 
3.06 (dt, 1H, J=4.9, 11.5 
Hz) 
26.0 
3.04 (dddd, J=1.4, 4.7, 11.5 
Hz) 
26.0 
16 - 107.2 - 107.2 
17 7.70 (s, 1H) 156.4 7.71 (d, J=1.4 Hz) 156.3 
18 1.33 (d, 3H, J=6.6 Hz) 14.3 1.34 (d, J=6.8 Hz) 14.2 
19 
4.75 (dd, 2H, J=4.1, 6.6 
Hz) 
73.0 4.75 (qd, J=6.8, 4.2 Hz) 72.9 
20 2.68 (t, 1H, J=11.5 Hz) 38.5 
2.67 (dddd, J=4.1, 4.2, 11.5, 
13.0 Hz) 
38.5 
21 
4.87 (overlapped with 
CD3OD) 
4.61 (dd, 1H, J= 13.3, 13.0 
Hz) 
57.6 
4.88 (β, dd, J=13.3, 4.1 Hz)  
4.59 (α, dd, J=13.3, 13.0 Hz)  
57.6 
22 - 168.4 - 168.4 
22-OMe 3.77 (s, 3H) 51.8 3.82 (s) 51.8 
 
The structure of alkaloid VI was deduced from analyses of the 2D NMR data, 
including COSY, HMQC and 
1
H-
13
C HMBC spectra in methanol-d4 (Figure 3.27). The 
COSY and HMQC spectra revealed connectivities of five partial structures a-e; a (H-9 
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to H-12), b (H-5 to H-6), c (H-14 to H-15), d (H-20 to H-21) and e (H-18 to H-19) 
(Figure 3.27). 
The 
1
H-
13
C HMBC cross-peaks of H-10 to C-8 and H-6 to C-8 and C-2 revealed 
the connection of partial structure a, b and attachment of partial structure b to indole 
moiety, while 
1
H-
13
C HMBC cross-peaks H-14 to C-20, C-2, H-18 to C-20 revealed the 
connection of partial structure c, d, e and attachment of partial structure c to indole 
moiety. The presence of a methyl carboxylate moiety at C-16 and an isolated sp
2
 
methine at C-17 were deduced by 
1
H-
13
C HMBC correlation between H-17 with C-22 
(Figure 3.27).  
N-
N+
O
MeOOC
11
12 13
8
10 9
7
2
3
14
15
16
1722
20 19
18
21
56
1H-13C HMBC
a
b
c
d
e
(104)
COSY
 
Figure 3.27: COSY and selected 
1
H-
13
C HMBC correlation of alkaloid VI 
 
Therefore, the identity of alkaloid VI was confirmed as the known corynanthean 
indole alkaloids, serpentine (104) by thorough analysis together with comparison of 
1
H 
and 
13
C NMR data of literature.
104
 (Table 3.6) 
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3.8 Alkaloid VII: Vindogentianine (136) 
N
Me
N
OCOMe
H
HO COOMe
H
11
10
9
12
13
8
7
2
6
5
3
14
1520
18
19'17
16
21
22
N
O
O
MeO
3'
4'
5'
6'7'
8'
1'
2'
9'10'
(136)  
Alkaloid VII,     
   -134° (c 1.0, MeOH) was isolated as yellowish brown 
amorphous solid. ESIMS spectrum showed a pseudomolecular ion peak at m/z 632 
(M+H)
+
. The molecular formula C35H41N3O8 was established by ESI-TOFMS [m/z 
632.3060 (M+H
+
), Δ +8.9 mmu] and [m/z 676.2897 (M+HCOO-), Δ +2.7 mmu]. IR 
absorptions implied the presence of hydroxyl (3458 cm
-1
) and ester carbonyl (1741 cm
-
1
) functionalities.
97
 Alkaloid VII showed UV maxima of      
           : 216 (4.46), 
259 (4.11) and 310 (4.01) nm thus suggesting the presence of dihydroindole moiety.
98
 
 Analysis of the 
1
H and 
13
C NMR data (Table 3.7) and the HMQC spectrum of 
alkaloid VII revealed the presence of four sp
3
 methine, six sp
3
 methylene, six methyl, 
six sp
2
 methine and thirteen quaternary carbons. Examination on the 
1
H and 
13
C NMR 
spectra of alkaloid VII revealed the characteristic feature of vindoline (4). Ethyl moiety 
was exhibited in 
1
H and 
13C NMR at δH 1.01 & 1.56, δC 30.8 and δH 0.49, δC 7.8 for 
methylene at C-19 and methyl at C-18 respectively. Two olefinic cis proton H-14 and 
H-15 were observed at δH 5.84 and δH 5.20 respectively.  Two strong methoxy singlets 
at δH 3.74 and δH 3.72 that belong to 22-OMe and 11-OMe respectively. The presence 
of an acetoxyl functionality was indicated by the resonance at δC 171.0 with the 
corresponding acetyl resonance at δC 21.2. The 
1
H NMR of alkaloid VII revealed a 
Alkaloids Isolated from Catharanthus roseus Chapter 3 
  
 
 80 
 
disubstituted indole aromatic system with only two singlet proton signals for H-9 and 
H-12 at δH 6.57 and δH 6.00 respectively.   
 The vindoline (4) skeleton occupied twenty five carbons, whereas alkaloid VII 
has thirty five carbons. Therefore, the other subunit must consist of ten carbons; one sp
3
 
methine, two sp
3
 methylene, one methyl, two sp
2
 methine and four quaternary carbons. 
The 
13
C NMR showed the C-1’ carbonyl signal at δC 164.3 with the corresponding ethyl 
resonance at δC 66.6 (C-8’) and δC 23.9 (C-7’). Two highly downfield signals at δC 
149.5 (C-3’) and δC 152.2 (C-4’) are due to two aromatic aminomethine.  
The other hydrogen atoms have six degree of unsaturation suggested the 
presence of six membered lactone fused together with a pyridine ring. The structure of 
the ten carbons subunit was deduced from analyses of the 2D NMR data, including 
COSY, HMQC and 
1
H-
13
C HMBC spectra (Figure 3.32). The COSY and HMQC 
spectra revealed connectivities of 2 partial structures consisted of –OCH2CH2- and -
CHCH3 in the ten carbons subunit.  
 Beside the proton signals resembling vindoline (4) subunit in the 
1
H-NMR 
spectrum of alkaloid VII,  two highly downfield aromatic protons were observed at δH 
9.06 (H-3’) and δH 8.58 (H-4’) confirmed the presence of pyridine system. In addition, 
one oxymethylene and methine signals overlap at δH 4.48 (H-8’ & H-9’), one methylene 
(δH 2.93, H-7’) and one methyl (δH 1.48, H-10’) protons were observed.  
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NO
O
1'
2'
3'
4'5'6'7'
8'
9'
10'
(137)  
Table 3.7: 
1
H and 
13
C-NMR Data for Alkaloid VII compared with 
1
H literature of 
vindoline (4)
99-101
 and gentianine (137)
105
.  
Position 
 
Alkaloid VII 
Vindoline 
(4) 
Gentianine 
(137) 
δH δC δH δH 
2 3.68 (s, 1H) 83.4 3.75 - 
3 
3.44 (α, dd, 1Ha, J=4.5, 16.3 Hz) 
2.83 (β, d, 1Hb, J=16.3 Hz) 
51.0 3.40 - 
5 
3.36 (α, ddd, 1Ha, J=4.4, 9.2, 13.8 Hz) 
2.49 (β, dd, 1Hb, J=6.9, 10.6 Hz) 
51.4 2.1-3.0 - 
6 
2.21 (ddd, 1H, J=2.3, 6.9, 13.8 Hz) 
2.01 (m, 1H, overlap with HCOMe) 
44.2  - 
7 - 53.2 - - 
8 - 124.1 - - 
9 6.57 (s, 1H) 120.6 6.91 - 
10 - 122.8 6.30 - 
11 - 157.6 - - 
12 6.00 (s, 1H) 93.4 6.08 - 
13 - 152.4 - - 
14 5.84 (dd, 1H, J=4.5, 10.1 Hz) 124.6 5.88 - 
15 5.20 (d, 1H, J=10.1 Hz) 130.4 5.23 - 
16 - 79.8 - - 
17 5.34 (α, s, 1Ha) 76.5 5.43 - 
18 0.49 (t, 3H, J=7.3 Hz) 7.8 0.48 - 
19 
1.56 (α, q, 1Ha, J=7.3 Hz) 
1.01 (β, q, 1Hb, J=7.3 Hz) 
30.8 1.35 - 
20 - 42.9 - - 
21 2.64 (s, 1H) 66.4 2.65 - 
22 - 171.9 - - 
COMe 2.03 (s, 3H) 21.2 2.07 - 
NMe 2.65 (s, 3H) 38.7 2.68 - 
11-OMe 3.74 (s, 3H) 55.7 3.80 - 
22-OMe 3.72 (s, 3H) 52.4 3.80 - 
OCOMe - 171.0 - - 
1’ - 164.3 - - 
2’ - 138.6 - - 
3’ 9.06 (s, 1H) 149.4 - 9.06 
4’ 8.58 (s, 1H) 152.2 - 8.84 
5’ - 121.1 - - 
6’ - 146.5 - - 
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7’ 2.92 (m, 2H, overlapped with H3) 23.9 - 3.00 
8’ 4.48 (m, 2H, overlapped with H9’) 66.6 - 4.54 
9’ 4.48 (m, 1H, overlapped with H8’) 31.7 - 5.77, 5.98 
and 7.08 10’ 1.48 (d, 3H, J=7.3 Hz) 21.0 - 
 
The 
1
H-
13
C HMBC cross-peaks of H-10’ to C-10 and H-9’ to C-11 confirmed 
that both the gentianine (137) and vindoline (4) moieties were connected through the C-
9’/C-10 bridge. Pyridine ring was trisubstituted with the lactone ring and a methylated 
methane carbon. This hypothesis was proven by the 
1
H-
13
C HMBC correlation between 
H-7’/C-2’, H-8’/C-1’, H-8’/C-6’ and H-9’/C-5’. 
10
N
O
O
3'
4'
5'
6'7'
8'
1'
2'
9'
10'
11
1H-13C HMBC
COSY
(136)  
Figure 3.32: COSY and selected 
1
H-
13
C HMBC correlation of alkaloid VII. 
 
 
Therefore, the identity of alkaloid VII as the new plumeran indole alkaloids with 
substitution of gentianine subunit at C-10 named as vindogentianine (136), was 
confirmed by thorough analysis of 2D NMR that include HMQC, COSY and 
1
H-
13
C 
HMBC together with comparison of 
1
H NMR data of vindoline (4)
99
 and gentianine 
(137)
105
 literature value.  
Vindogentianine (136) could be formed from the known plumeran alkaloid, 
vindoline (4) and gentianine (137). Through literature, it was found that gentianine 
(137) was an artefact form from degradation of gentiopicroside (138), a secoiridoid 
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glycoside.
106; 107
 Gentiopicroside (138) is chemically unstable, it can be transformed into 
gentianine (137) and gentinal (139) in the presence of ammonium (Figure 3.33).
105; 108
 
Therefore, the existence of vindogentianine (136) was believed to be an artefact.  
OO
O
OGluc
NO
O
NHO
O
CHO
O
+
NH4
+
(138) (137) (139)  
Figure 3.33: Condensation of gentiopicroside (138) with ammonium 
Gentiopicroside (138) commonly existed in gentianceous plants especially in the 
genera of Gentiana and Swertia (Gentianaceae family).
108
 Loganic acid (140), the 
iridoid glycoside that responsible for the formation of monoterpenoid indole alkaloids in 
Apocynaceae plants was also found to be the precursor for the formation of 
gentiopicroside (138) in Swertia plants. Loganic acid (141) firstly undergoes 
hydroxylation to loganin (142) before ring cleavage to have an aldehyde moiety. Trans 
esterification with the aldehyde moiety will afford a lactol reminiscent like in sweroside 
(143). Lastly, dehydrogenation of sweroside (144) will give gentiopicroside (138) 
(Figure 3.34).
106
 
Gentianine (137) is ubiquitous in plants from the family Gentianaceae, 
especially in the genera of Gentiana and Swertia. 
108; 109
 It has been reported to occur in 
Alstonia and Hunteria of Apocynaceae family.
110-113
  However, this is the first report of 
the occurrence of an alkaloid linked to gentianine (137) moiety. 
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OO
O
OGluc
(138)
OO
O
OGluc
(143)
O
OGluc
HOOC
OHC
O
OGluc
(142)
HOOC
HO
O
OGluc
(141)
HOOC
 
Figure 3.34: Biosynthesis of gentiopicroside (138) from loganic acid (141) in Swertia 
plants. 
106
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4.1 Bioactivity screening 
Type I diabetes develops through autoimmune destruction of islet β-cells while 
dysregulation of insulin secretion from β-cells leads to type II diabetes.114  Islet has poor 
deoxyribonucleic acid (DNA) repair capacity against oxidative damage and β-cells are 
vulnerable to oxidative stress. In diabetic individuals, there are imbalance of reactive 
oxygen species (ROS) generation and neutralization. Oxidative stress that damage cells 
plays a central role in the development of diabetic complication, insulin resistance and 
β-cells dysfunction.115  
The present study was undertaken to scientifically investigate antidiabetic 
potential of Catharanthus roseus’ dichloromethane extract (DE) and the isolated 
alkaloids using in vitro mouse pancreatic β-TC6 cells. Firstly, the β-TC6 cells were 
evaluated for cytotoxicity and cell proliferation together with antioxidant potential 
employing oxygen radical absorbance capacity (ORAC) assay. Furthermore, the DE and 
alkaloids effects on in vitro glucose uptake in β-TC6 cells using 2-[N-(7-nitrobenz-2-
oxa-1,3-diaxol-2-yl)amino]-2-deoxyglucose (2-NBDG) were tested. Lastly, the 
mechanism of hypoglycemic activity that exhibited by selected alkaloids were evaluated 
through inhibition of the negative regulator of insulin signalling pathway, PTP-1B.   
β-TC6 cells are derived from transgenic SV40 mice. It is an insulinoma cell 
lines that produced and secreted insulin in response to glucose stimulus. This cell line 
exhibited a 1.6-fold increase in insulin secretion in response to glucose stimulus, with a 
half-maximal response at 0.5 mM glucose. This cell line was also found to secrete 
glucagon and somatostatin.
114
 Glucagon is a peptide hormone secreted by the pancreas, 
raises blood glucose levels.
116
 Somatostatin is a peptide hormone that regulates the 
endocrine system and affects neurotransmission and cell proliferation.
117
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Glucose uptake ability evaluation in cells plays a fundamental role in diabetes 
mellitus research because there is a failure to increase glucose uptake into peripheral 
tissues in response to insulin in diabetes patient.
118
  2-NBDG is a fluorescent derivative 
of glucose that showed intense fluorescence at 542 nm when excited at 467 nm.
119
 PTP-
1B is a negative regulator of the insulin signaling pathway in human and is considered a 
promising potential therapeutic target for treatment of type 2 diabetes. For example, 
PTP-1B knock-out mice showed hyper obesity and proned to the development of type-2 
diabetes.
120-122
 
Colorimetric assays using the tetrazolium salt thiazolyl blue, also termed MTT 
(methyl-thiazolyl-tetrazolium) are widely used for assessment of cytotoxicity and 
proliferation studies in cell biology.
123-126
 MTT gives a yellowish aqueous solution 
which will be reduces by dehydrogenases and reducing agents present in metabolically 
active cells to yield a water insoluble violet-blue formazan that can be estimated by 
spectrophotometer at 595 nm. The amount of MTT formazan is directly proportional to 
the number of living cells.
126
  
ORAC is an integrative method for estimation of antioxidant capacity mainly for 
foods and beverages in United State of America.
127
 In this study, antioxidant capacity 
was evaluated from the area under the curve (AUC) of the kinetic profiles of 
fluorescein. AUC values are compared with Trolox, a hydrosoluble vitamin E analog. 
Thus, allowing determination of ORAC index in terms of this reference compound. In 
ORAC assay, secondary reactions or even reactions associated with repair mechanism 
can be present.
128
 Antioxidant-metal reaction could result in a lower concentration of 
antioxidants and therefore to an under-estimation of ORAC value.
129
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4.2 Effect of alkaloid on β-TC6 cell viability 
The alkaloids were evaluated for cytotoxic activity on β-TC6 cells. The results 
were summarized in Table 4.1. The cells were treated for 24 hours with various 
concentrations of extracts and alkaloids. Cell viability was determined by MTT assays.  
IC50 of extracts (HE, DE, ME & WA), vindoline (4), vindorosine (65), 
vindolicine (90) and serpentine (104) vindogentianine (136)  exceeded 50 µg/mL, while, 
vindolinine (9)  showed lowest IC50 at 20.5 ± 3.6 µg/mL followed by perivine (45) at 
46.7 ± 4.4 µg/mL. On the other hand, doxorubicin, the standard drug exhibited IC50 at 
3.8 ± 1.7 µg/mL. The present study demonstrated for the first time that these extracts, 
vindoline (4), vindorosine (65), vindolicine (90), serpentine (104) and vindogentianine 
(136) are safe at high dosage, but vindolinine (9) and perivine (45) exhibited moderate 
cytotoxic effect against β-TC6 cells. 
Table 4.1: Cell viability and ORAC in β-TC6 cells with treatment of extracts and 
alkaloid I-VII. 
Extract/alkaloid 
Cell viability IC50 ORAC 
TE ± SD µM µg/ml µM 
HE 68.0 - 134.0 ± 7.1 
DE 78.4 - 66.5 ± 12.0 
ME 165.2 - 18.0 ± 21.2 
WA 232.4 - 87.0 ± 41.0 
Vindoline (4) 82.1 ± 9.8 180.1 ± 21.5 41.0 ± 12.7 
Vindolinine (9) 20.5 ± 3.6 57.6 ± 10.7 61.0 ± 19.8 
Perivine (45) 46.7 ± 4.4 138.2 ± 13.0 29.0 ± 11.3 
Vindorosine (65) 76.7 ± 8.1 180.1 ± 19.0 92.0 ± 11.3 
Vindolicine (90) 68.0 ± 10.4 73.5 ± 11.3 185.5 ± 4.9 
Serpentine (104) 62.5 ± 5.3 179.6 ± 15.2 24.0 ± 21.2 
Vindogentianine (136) 110.7 ± 7.5 175.4 ± 11.9 64.5 ± 13.4 
 
4.3 Oxygen radical absorbance capacity (ORAC) evaluation 
The ORAC results were expressed as Trolox equivalent (TE). Net area under the 
curve  (AUC) with increasing dosage of Trolox demonstrated a linearity correlation 
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with R
2
 value 0.9668. (Figure 4.1) Quercetin, the positive control demonstrated highest 
TE value at 406.5 ± 2.1 µM. Out of the four extract tested for ORAC, only HE and DE 
showed significant activity at (134.0 ± 7.1 µM) and (66.5 ± 12.0 µM) respectively. Of 
all the isolated pure alkaloids, vindolicine (90, 185.5 ± 4.9 µM) demonstrated the 
highest antioxidant property followed by vindorosine (65, 92.0 ± 11.3 µM), 
vindogentianine (136, 64.5 ± 13.4 µM), vindolinine (9, 61.0 ± 19.8 µM), vindoline (4, 
41.0 ± 12.7 µM), perivine (45, 29.0 ± 11.3 µM) and serpentine (104, 24.0 ± 21.2 µM). 
The activity exhibited in DE extract may be due to the extract contain high abundance 
of vindoline (4), and minute quantity of vindolinine (9), vindorosine (65), vindolicine 
(90), vindogentianine (139).  
 
Figure 4.1: Net AUC with increasing dosage of Trolox correlation. 
 
 
4.4 Effect of alkaloid on glucose uptake in β-TC6 cells 
Improving glucose uptake in pancreatic cells could improve hyperglycemia 
condition of type 2 diabetes. The fluorescent glucose 2-NBDG could be visualized 
around cytosol in β-TC6 cells treated with DE and the alkaloids: vindoline (4), 
vindolinine (9), vindorosine (65), vindolicine (90) and vindogentiamnine (136). (Figure 
4.3) 
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Figure 4.2: ORAC activity of extracts and alkaloids I-VII isolated from Catharanthus 
roseus leaves. Quercetin is included as positive control. (405 ± 2.1 µM) 
 
DE dose-dependently increased glucose uptake, albeit the activity was relatively 
lower compare to the positive control, insulin (Figure 4.4).  Among the 5 pure alkaloids, 
vindolicine (90) stimulated the highest glucose uptake in beta cells with more than 3 
fold enhancement in glucose uptake compared to untreated control at 12.5 μg/mL 
(Figure 4.4). Glucose clearance rates in vindoline (4), vindolinine (9), vindorosine (65) 
and vindogentianine (136) treated β-TC6 cells were significantly higher after treatment 
(Figure 4.4). The weakest enhancement in glucose uptake was in beta cells treated with 
vindogentianine (136) with only 90 % increase glucose uptake was observed as 
compared to untreated beta cells at of 12.5 μg/mL (Figure 4.4). 
At higher dosage (50.0 μg/mL), vindolinine (9) was cytotoxic towards β-TC6 
cells (Figure 4.4). At the highest dosage (100.0 μg/mL), all five alkaloids exhibited 
cytotoxicity with large deviation on the reading of fluorescence intensity obtained 
(Figure 4.4). The results of glucose uptake showed in Figure 4.4 have p<0.05, except 
vindolinine at 50.0 μg/mL and all the treatment at 100.0 μg/mL. 
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Figure 4.3: Representative photo showing enhanced glucose uptake by β-TC6 after 
treated with 25 µg/mL of selected alkaloids. Blue:Hoechst, Green: 2-NBDG 
Vindorosine 
+2-NBDG 
Hoechst 2-NBDG Merged 
Untreated 
+2-NBDG 
Vindolicine+2-
NBDG 
Vindolinine+2
-NBDG 
Vindoline 
+2-NBDG 
  
Vindogentianine 
+2-NBDG 
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Figure 4.4: Bar chart showing fluorescent intensity of 2-NBDG taken up by β-TC6 
cells. Insulin was included as positive controls. (A) 12.5 µg/mL, (B) 25.0 µg/mL, (C) 
50.0 µg/mL and (D) 100.0 µg/mL 
 
4.5 Effect of alkaloid on PTP-1B inhibition 
The development of novel pharmaceutical agents that help ameliorate insulin 
resistance will be potentially important for the prevention and treatment of diabetes. 
PTP-1B is an enzyme that belongs to the Protein Tyrosine Phosphatase (PTP) family 
and a negative regulator of the insulin signaling pathway. To further evaluate 
antidiabetic potential of these compounds, we performed in vitro PTP-1B inhibition 
assays to determine whether four of the alkaloids, vindoline (4), vindolinine (9), 
vindorosine (65) and vindolicine (90) that exhibit highest activity in glucose uptake 
were active inhibitors of PTP-1B. Vindolicine (90) showed the highest inhibition 
activity follow by vindolinine (9), vindorosine (65) and vindoline (4).  However, the 
activity of vindolicine (90) was relatively weaker as compared to the positive controls; 
RK-682 and ursolic acid (Figure 4.5).  
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Figure 4.5: PTP-1B inhibition of selected alkaloids compared against positive control 
drugs RK-682 and Ursolic acid. 
 
4.6 Discussion 
In this study, the cytotoxicity and antioxidant potential of all the extracts were 
evaluated first by employing oxygen radical absorbance capacity (ORAC) assay in β-
TC6 cells (normal pancreatic cells). The result of cytotoxicity and ORAC of DE 
directed for more detailed study of their alkaloids constituents because it showed 
significant Trolox equivalent (TE) value at 66.5 ± 12.0 µM as compared to the other 
extract that showed high standard deviation in this assay except HE. However, HE was 
not chosen to undergo alkaloid constituent study because it showed higher cytotoxicity 
against β-TC6 cells.  
DE exhibited antioxidant and antidiabetic activity in β-TC6 mouse pancreatic 
cells. Moreover, it showed less cytotoxicity effect towards β-TC6 cells at high 
concentration. Based on these findings, there is a need to study the constituents from the 
active extract to discover the compound/s responsible for the antioxidant and 
hypoglycemic properties.We performed ORAC assay to assess the antioxidant property 
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of the alkaloids. Vindolicine (90) indicated the highest antioxidant property, followed 
by vindorosine (65) in ORAC values.  
Out of the seven alkaloids successfully isolated from the DE, only plumeran 
alkaloids that include vindoline (4), vindolinine (9), vindorosine (65), vindolicine (90) 
and vindogentianine (136), were subjected to antidiabetic study by glucose uptake assay. 
Corynanthean alkaloids; Perivine (45) and serpentine (104) were not selected to 
undergo these studies because they showed weak ORAC with insignificant TE value at 
29.0 ± 11.3 and 24.0 ± 21.2 µM respectively. Meanwhile, only the four best alkaloids in 
glucose uptake were subjected to PTP-1B inhibition evaluation.  
In present study, the antidiabetic activity of vindorosine (65), vindolicine (90) 
and vindogentianine (136) have been shown for the first time. The five alkaloids tested 
showed enhanced glucose uptake with dose dependent activity as compared with 
untreated β-TC6 cells. The lower dosage could provide antioxidant effect to β-TC6 
cells, which promoted cellular activity, and led to the increase of glucose uptake. 
Cytotoxic effect (MTT IC50 = 20.5 ± 3.6 µg/mL) was observed in higher concentration 
of 50.0 µg/mL for vindolinine (9) and the other alkaloids at 100.0 µg/mL. Vindolicine 
(90) showed the greatest enhancement in glucose uptake. At the lowest dosage (12.5 
µg/mL), the degree of glucose uptake increase in the order of vindogentianine (136), 
vindoline (4), vindorosine (65), vindolinine (9) and vindolicine (90), correlating with its 
PTP-1B inhibition activity, indicating that PTP-1B signaling could play a role in 
controlling cellular glucose uptake activity in β-TC6 cells. 
To the best of our knowledge, this is the first report on PTP-1B inhibition study 
on all the four alkaloids; vindoline (4), vindolinine (9), vindorosine (65) and vindolicine 
(90). These findings indicated that vindolicine (90) possessed the highest inhibition 
activity compared to the other three alkaloids. 
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5.1 Conclusion 
 The chemical constituents study on the leaves of Catharanthus roseus yielded 
six known indole alkaloids which are vindoline (4), vindolinine (9), perivine (45), 
vindorosine (65), vindolicine (90), serpentine (104) and a new indole alkaloids, 
vindogentianine (136). Structural elucidations were established through spectroscopic 
methods: NMR, MS, UV, IR, optical rotation, elemental analysis and comparison with 
literature values.   
 Vindogentianine (136) is formed from the condensation of vindoline (4) and 
gentianine (137). The latter is an artefact from reaction of ammonia with 
gentiopicroside (138). Gentianine (138) has never occurred in Catharanthus but it has 
been reported in several Apocynanceae plants.  
This study was also the first to show the cell viability of Catharanthus roseus 
extracts (HE, DE, ME, WA) and alkaloids from the leaves of Catharanthus roseus in 
normal mouse pancreatic cells, β-TC6 cells. The IC50 of extract decreases in the 
sequence of WA, ME, DE and HE with the most cytotoxic (IC50 = 68.0 µg/ml). 
Therefore, the consumption of water decoction from the leaves of Catharanthus roseus 
for diabetes treatment in traditional medicine practice considered safe, even though 
Catharanthus roseus contain many cytotoxic compounds. Evaluation of alkaloids 
isolated showed that most alkaloids were weakly cytotoxic except for vindolinine (9) 
and vindolicine (90) that showed moderate cytotoxicity against β-TC6 cells with IC50 of 
57.6 ± 10.7 µM and 73.5 ± 11.3 µM respectively. 
 Antioxidant potential of this plant evaluated through ORAC showed that this 
plant possessed highest potential in HE and followed by DE. However, ME and WA did 
not show reliable data for comparison in ORAC. Most plumeran alkaloids showed 
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relatively better antioxidant potential in ORAC as compared to corynanthean alkaloids 
such as perivine (45) and serpentine (104). Vindolicine (90) showed the highest 
antioxidant potential while the other alkaloids showed moderate or weak activity as 
compared to the positive control, quercetin.  
The glucose uptake assay in β-TC6 cells with treatment of DE supported the 
antidiabetic activity of this plant as known from some earlier report and traditional 
medicinal usage. Vindorosine (65), vindolicine (90) and vindogentianine (136) were 
shown to possess hypoglycemic activity for the first time. It showed increased glucose 
uptake with fluorescence intensity of 425.0 ± 1.4, 546.5 ± 16.3 and 237.0 ± 11.0 for 
vindorosine (65), vindolicine (90) and vindogentianine (136) at concentration of 12.5 
µg/mL compared with untreated β-TC6 cells (125.0 ± 25.0).  Among all the alkaloids 
tested for glucose uptake, vindolicine (90) was found to be the most hypoglycemic. 
PTP-1B inhibition was shown to be one of the mechanisms underlying the 
hypoglycemic observed.    
Therefore, vindolicine (90) is more beneficial and useful, relative to vindoline 
(4) or vindolinine (9) or vindorosine (65), for amelioration of type 2 diabetes due to its’ 
high antioxidant and PTP-1B inhibition activities. Vindolicine (90) being the most 
hypoglycemic and with the highest antioxidant activity is a good candidate to be 
investigated further as the source of new natural antidiabetic drug.  
At the end, this plant unveils more interesting chemical constituents with 
isolation of alkaloid with evidence of gentianine (137) biogenetic occurrence in this 
plant regardless of how extensively had this plant been studied. Furthermore, it was 
found that many of these known alkaloids from this plant are antidiabetic. The water 
extract showed the highest antidiabetic activity suggesting more study should be 
conduct into it in future.  
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6.1 Experimental 
UV spectra were obtained in methanol using a Shidmazu UV-1650 PC UV-Vis 
spectrophotometer at concentration of 1 mg/mL. IR spectra were obtained on a Perkin-
Elmer RX1 FT-IR spectrophotometer using potassium bromide pellets.  
Column chromatography was performed on silica gel 60 (0.063-0.200 or 0.040-
0.063 or 0.015-0.040 mm, MERCK) and Sephadex LH-20 (GE Healthcare Bio-Sciences 
AB). Fractions were monitored by TLC (silica gel 60 F254 of MERCK) and spots were 
visualized under UV light (Spectroline Model ENF-260C/FE, 250V, 50 Hz and 0.17 
AMPS) at wavelength of 254 nm and 365 nm followed by Dragendorff’s reagent. 
Preparative TLC silica gel 60 F254 (250 µm) of MERCK was used in purification. All 
solvents except those used for bulky extraction (distilled) were AR grade.  
 
6.2 Plant material 
Catharanthus roseus (L.) G. Don. was cultivated at Jeli, Kelantan, Malaysia 
from November 2008 under natural condition. The leaves were collected around May 
2009 and dried at 40 °C. The specimen was authenticated by Mr. Teo Leong Eng, a 
botanist in the Faculty of Science, University of Malaya. A voucher specimen with 
Herbarium No. of KL 5763 was deposited at the Herbarium of the Department of 
Chemistry, University of Malaya, Kuala Lumpur, Malaysia.  
6.3 Extraction and fractionation 
The dried leaves of Catharanthus roseus (1 kg) were sequentially extracted with 
n-hexane, dichloromethane and methanol. Firstly, dried grounded leaves of 
Catharanthus roseus (1 kg) was macerated with n-hexane (Hex) for 3 days at room 
temperature and was repeated twice. After removal of solvent, the plant residue was 
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first wetted with 25% ammonia for an hour followed by soaking with dichloromethane 
(DCM) by repeating the previous steps described for hexane extraction. After percolated 
with DCM, methanol (MeOH) was used as the final solvent to achieve universal 
extraction of the remaining metabolites in the leaves. Another 1 kg of the dried leaves of 
Catharanthus roseus were extracted with water under reflux for 3 hours. Water extract 
was obtained after freeze drying. As a result, we are able to obtain hexane (HE, 65.6 g), 
dichloromethane (DE, 44.5 g), methanol (ME, 252.4 g) and water (WA, 285.3 g) extract 
of Catharanthus roseus leaves (Table 6.1). 
DE was used for studying the alkaloid constituents in the Catharanthus rosues 
leaves. DE (42.6 g) was subjected for acid-base extraction using 5% hydrochloric acid 
and 25% ammonia solution to obtain 4.2 g of crude alkaloid (DA) (Figure 6.1). DA was 
subjected to column chromatography (CC) with silica gel 60 (Merck, Germany) using 
gradient elution from DCM (100%) and DCM-MeOH (95:5, 90:10, 85:15, 80:20, 75:25, 
70:30, 65:35, 60:40, 55:45, 50:50, v/v). The CC was later flushed using DCM-MeOH 
(40:60, 20:80, v/v) and MeOH (100%). Each different solvent system, 1000 mL were 
used for elution. The eluent was collected in fractions of 100 mL. Those fractions with 
the same TLC profile were then combined. A total of 15 fractions were obtained 
(Fractions 1-15). 
Table 6.1: Weight and percentage yield of different extraction solvent. 
Extract Weight (g) Percentage Yield (%) 
HE 65.5 6.55 
DE 44.5 4.45 
ME 252.4 25.24 
WA 285.3 28.53 
 
6.4 Isolation and purification  
Fraction 3 (855.4 mg) was subjected to preparative TLC (PTLC) separation 
using Hex-EA-Acetone (20:78:2, v/v/v) under ammonia vapour on TLC silica gel 60  
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F204 (Merck Germany) to yield alkaloid I: vindoline (4, 428.1 mg) and alkaloid IV: 
vindorosine (65, 57.9 mg). Fraction 4 (171.3 mg) was applied to PTLC with Hex-EA-
Acetone (20:79:1, v/v/v) under ammonia vapour to yield alkaloid VII: vindogentianine 
(136, 38.6 mg) and alkaloid V: vindolicine (90, 31.0 mg). PTLC of fraction 6 (79.1 mg) 
using the same solvent system as applied on fraction 4 yielded alkaloid II: vindolinine 
(9, 8.4 mg) (Table 6.2 & Figure 6.2). 
Fraction 9 (435.7 mg) was subjected to silica gel 60 (Merck, Germany) CC 
using gradient elution of the following composition: Hex:EA (70:30, 65:35, 60:40, 
55:45, 50:50, 45:55, v/v) and EA (100%). Each 100 mL of different solvent system with 
5 mL of TEA was used for elution. The eluent was collected in fractions of 10 mL. Sub-
fractions with the same TLC profile were then combined based on 
1
H NMR profiles to 
yield 9 sub-fractions. Sub-fraction 2 was subjected to PTLC using Hex-EA (60:40, v/v) 
with 5 mL of TEA to yield alkaloid III: perivine (45, 7.9 mg) (Table 6.2 & Figure 6.2). 
Fraction 12 (67.8 mg) was chromatographed on sephadex LH-20 (GE 
Healthcare, Sweden) CC using MeOH-DCM (90:10, v/v, 160 mL) for elution. The 
eluent was collected in fractions of 10 mL to yield 14 sub-fractions. Sub-fractions 11-14 
gave alkaloid VI: serpentine (104, 5.6 mg) (Table 6.2 & Figure 6.2).  
Table 6.2: Chromatographic fractionation solvent and their respective alkaloids isolated 
with yield. 
Solvent ratio 
DCM:MeOH 
Fraction Alkaloid 
Weight 
(mg) 
Yield (%) 
80:20 3 
I: Vindoline (4) 428.1 1.005 
IV: Vindorosine (65) 57.9 0.136 
75:25 4 
VII: Vindogentianine (136) 38.6 0.091 
V: Vindolicine (90) 31.0 0.073 
65:35 6 II: Vindolinine (9) 8.4 0.020 
55:45 9 III: Perivine (45) 7.9 0.019 
50:50 12 VI: Serpentine (104) 5.6 0.013 
 
 
Experimental Chapter 6 
 
 
 105 
 
 
F
ig
u
re
 6
.2
: 
C
h
ro
m
at
o
g
ra
p
h
ic
 d
ia
g
ra
m
 o
f 
al
k
al
o
id
 I
-V
II
 f
ro
m
 D
A
 
Experimental Chapter 6 
 
 
 106 
 
6.5 Identification and characterization of alkaloids 
One-dimensional and two-dimensional of 
1
H and 
13
C NMR experiments were 
carried out on a JEOL ECA 400 FT-NMR for vindoline (2), vindolinine (7), perivine 
(43), vindorosine (63), vindolicine (90), vindogentianine (139) and Bruker Ultrashield 
600 plus FT-NMR with smartprobe for serpentine (130). CDCl3 was used as the solvent 
for vindoline (2), vindolinine (7), vindorosine (63), vindolicine (90) and 
vindogentianine (139). Meanwhile, CD3OD was the solvent for perivine (43) and 
serpentine (130). The chemical shift (δ) were recorded with reference to that of solvent, 
CDCl3 (7.24 ppm) or CD3OD (3.78 ppm) and the coupling constants were given in 
Hertz (Hz). 
LC-MS for identification was carried out on Shimadzu LCMS-IT-TOF equipped 
with pump (LC-20AD), autosampler (SIL-20AC), column oven (CTO-20AC), PDA 
detector (SPD-M20A) and coupled to ESI interface (Shimadzu, Kyoto, Japan). Isolated 
compounds (5 µL) were injected and chromatographed on Waters XBridge C18 2.5 mm 
(2.1 x 50 mm) column with the mobile phase of A (0.1% formic acid in water) and B 
(0.1 % formic acid in MeOH). The mobile phase was performed in a step gradient as 
follows: isocratic 10% B for 2 min, 10% B to 100% B over the next 25 min and 
isocratic at 100% B for 5 min. The system was re-equilibrated for 5 min before the next 
run. Eluent were monitored using DAD at 220 nm, 254 nm, 350 nm and 450 nm. ESI-
MS was performed in the range 100-2000 in both the positive and negative mode. The 
temperature of the heat block and curved desolvation line (the inlet for the high vacuum 
region) were set to 200°C and 250°C, respectively. Nitrogen gas was used as nebulizer 
with the flow rate set at 1.5 L/min. The ESI source voltage was set at 4.5 kV for positive 
mode and -3.5 kV for the negative mode whereas the detector was maintained at 1.7 kV. 
Shimadzu’s LCMS solution software was used for data analysis. 
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6.6 Cell culture  
Mouse β-TC6 cells were purchased from American Type Culture Collection 
(ATCC, Manassas, VA, USA) and cultured in 15% fetal bovine serum (FBS) in 
Dulbecco’s Modified Eagle Medium (DMEM). The cultures were kept in a humidified 
incubator at 37ºC in 5% CO2 and the growth medium was changed every 3 days. 
6.7 Cellular viability 
The β-TC6 cells were used to determine the effect of extracts and alkaloids on 
cell growth by MTT assay.134 Briefly, 1.5 × 10
4
 β-TC6 cells were seeded into a 96-well 
plate and incubated at 37°C in 5% CO2 for 24 h. The second day, the seeded cells were 
treated with alkaloids and extracts. After another 24h of incubation, MTT solution was 
added at 2 mg/mL and the plates were kept in incubator at 37°C in 5% CO2 for 1 h. 
Absorbance at 570 nm was measured by a Plate Chameleon V microplate reader (Hidex, 
Turku, Finland). The obtained values are expressed as a percentage of cell viability after 
exposure to extracts and alkaloids for 24h. Cell viability was defined as the ratio 
(percentage) of the absorbance of treated cells to that of untreated ones. 
6.8 Oxygen radical absorbance capacity (ORAC) 
The ORAC assay was carried out based on the procedure described by Cao et al. 
(1993) with slight modifications.
130
 In brief, the sample/blank (175 μL) was dissolved in 
PBS at the concentration of 160 μg/mL at pH 7.4. The standard Trolox was prepared in 
serial dilutions starting from 75 mM. Standard 96-well black microplates was used for 
the assay, and 25 μL each of the samples (extract and alkaloids), standard (Trolox), 
blank (solvent/PBS), or positive control (quercetin) were added to the wells. Fluorescent 
sodium salt solution was added at 150 μL per well, followed by incubation at 37°C for 
45 min. The total volume of each well was made up to 200 μL by adding 2,20-azobis 
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(2-amidinopropane) dihydrochloride (AAPH) solution. Fluorescence value was 
recorded at 37°C until it became 0 (excitation at 485 nm, emission at 535 nm) using a 
fluorescence spectrophotometer (Perkin-Elmer LS 55) equipped with an automatic 
thermostatic autocell-holder. Data were collected every 2 min for 2 h and the data 
analysis was subsequently done by calculating the differences of areas under the 
fluorescein decay curve (AUC) between the blank and the sample. The resulted values 
were expressed as Trolox equivalents. 
6.9 2-NBDG glucose uptake 
The cells were seeded at a density of 1.5 × 10
4
 cells/mL in a 96-well plate and 
allowed to attach, spread, and proliferate to near confluence at 37°C in 5% CO2. After 
overnight incubation, the medium was discarded, washed with phosphate-buffered 
saline (PBS) twice and replenished with 2.5 mM glucose in basal medium comprising 
DMEM without glucose or pyruvate supplemented with L-glutamine and 15% (v/v) 
FBS (final serum glucose concentration of approximately 0.25 mM). The cells were 
incubated for 60 min at 37°C in 5% CO2. The conditioning medium was then replaced 
with 10 mM 2-NBDG (Invitrogen) in basal medium in the presence or absence of DE 
and alkaloids. The cells were kept at 37°C in 5% CO2 for 30 min to permit endocytosis 
of the 2-NBDG. Next, the medium was removed, cells were washed twice with PBS and 
stained with nucleic dye Hoechst 33342 for another 30 min. The cells were then 
observed for intra-cellular fluorescence at Excitation/Emission = 350 nm/461 nm and 
Excitation/Emission = 475 nm/550 nm for Hoechst 33342 and 2-NBDG, respectively. 
Plates were evaluated using the ArrayScan High Content Screening (HCS) system 
(Cellomics Inc., Pittsburgh, PA, USA) and analyzed with Target Activation 
BioApplication software (Cellomics Inc.).
131
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6.10 PTP-1B inhibition 
The pNPP (para-Nitro Phenyl Phosphate) was used as substrate to assay the 
phosphatase activity.
132
 The ionic strength of the assay buffer (pH 7.4), was adjusted to 
0.15 M using NaCl. The buffer contains 50 mM 3,3-dimethyl glutarate, 1 mM EDTA, 
5 mM glutathione, and 0.5% FCS (not heat inactivated). Briefly, diluted (50 μM 
alkaloids) and undiluted inhibitors were added to the reaction mixture containing 0 or 
2.5  mM pNPP to reach the total volume of 100 μL. The enzyme (recombinant PTP-1B) 
was added to initiate the reaction. The reaction was allowed to proceed for 5 min before 
adding the inhibitor. The incubation was continued at 37°C for 5-60 min and the time 
was recorded. Then 20 μL 0.5 M NaOH in 50% ethanol was added to stop the reaction. 
To determine the enzyme activity, the absorbance was measured at 405 nm using Tecan 
ELISA reader with appropriate corrections for absorbance of substrate, alkaloids, and 
nonenzymatic hydrolysis of substrate. 
6.11 Statistical analysis 
Data were presented as means ± SEM and analyzed with unpaired Student’s t-
test in which p<0.05 is considered significant. 
6.12 General spectral data of the isolated alkaloids 
Vindoline (4)
97-101
 
N
Me
N
OCOMeH
COOMeHO
H
MeO 11 21
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12 13
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3
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(4)  
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Nature of isolate  : yellowish brown, amorphous solid 
Molecular formula  : C25H32N2O6 
Optical rotation  :     
   -46° (c 1.0, MeOH) 
UV (MeOH) λmax   : 224 (5.00), 251 (4.79) and 307 (4.63) nm 
IR (KBr) υmax   : 3458, 1741 and 1240 cm
-1
 
[M+H]
+ 
  : 457 m/z 
1
H-NMR   : 400 MHz; CDCl3; Me4Si (Refer Table 3.1) 
13
C-NMR   : 100 MHz; CDCl3; Me4Si (Refer Table 3.1) 
 
Vindolinine (9)
97-98;102
 
N
H
N
H
11
10 9
12 13
8
7
2
6
5
3
14
1520
21
18
19
MeOOC
16
17
22
(9)  
Nature of isolate  : brown, amorphous solid 
Molecular formula  : C21H24N2O4 
Optical rotation  :     
   -46° (c 1.0, MeOH) 
UV (MeOH) λmax   : 3365, 1725, 1466 and 1246 cm
-1
 
IR (KBr) υmax    : 216 (4.14), 244 (3.95), 295 (3.77) and 308 (3.71) nm 
[M+H]
+
   : 337 m/z 
1
H-NMR   : 400 MHz; CDCl3; Me4Si (Refer Table 3.2) 
13
C-NMR   : 100 MHz; CDCl3; Me4Si (Refer Table 3.2) 
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Perivine (45)
97;103
  
N
H
HN
O
MeOOC
H
16
18
19
20
15
6
5
3 21
7
2
14
8
910
11
12
13
22
(45)
H
H
 
Nature of isolate  : brown, amorphous solid 
Molecular formula  : C20H22N2O3 
Optical rotation  :     
   -76° (c 1.0, MeOH) 
UV (MeOH) λmax   : 228 (4.36), 296 (4.11) and 314 (4.29) nm 
IR (KBr) υmax    : 3311, 1725 and 1643 cm
-1
 
[M+H]
+
   : 339 m/z 
1
H-NMR   : 400 MHz; CD3OD; Me4Si (Refer Table 3.3) 
13
C-NMR   : 100 MHz; CD3OD; Me4Si (Refer Table 3.3) 
 
Vindorosine (65)
97-100
 
N
Me
N
OCOMeH
COOMeHO
H
11 21
22
14
15
18
16
17
12 13
2
10 9
6
5
3
19
8
7
20
(65)  
Nature of isolate  : brown, amorphous solid 
Molecular formula  : C24H30N2O5 
UV (MeOH) λmax   : 203, 252 and 308 nm 
IR (KBr) υmax    : 203 (4.16), 252 (3.83) and 308 (3.50) nm 
[M+H]
+
   : 427 m/z 
1
H-NMR   : 400 MHz; CDCl3; Me4Si (Refer Table 3.4) 
13
C-NMR   : 100 MHz; CDCl3; Me4Si (Refer Table 3.4) 
Experimental Chapter 6 
 
 
 112 
 
Vindolicine (90)
71;97-98
 
N
Me
N
OCOMeH
COOMeHO
H
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H2C
 
Nature of isolate  : brown, amorphous solid 
Molecular formula  : C51H64N4O12 
Optical rotation  :     
   -75° (c 1.0, MeOH) 
UV (MeOH) λmax   : 217 (4.61), 253 (4.37) and 308 (4.03) nm 
IR (KBr) υmax    : 3432, 1741 and 1241 cm
-1
 
[M+H]
+
   : 925 m/z 
1
H-NMR   : 400 MHz; CDCl3; Me4Si (Refer Table 3.5) 
13
C-NMR   : 100 MHz; CDCl3; Me4Si (Refer Table 3.5) 
 
Serpentine (104)
104
 
N-
N+
O
H
MeOOC
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Nature of isolate  : brown, amorphous solid 
Molecular formula  : C21H20N2O3 
Optical rotation  :     
   +60° (c 1.0, MeOH) 
UV (MeOH) λmax   : 251 (4.20), 308 (4.02) and 363 (3.58) nm 
 [M+H]
+
   : 349 m/z 
1
H-NMR   : 600 MHz; CD3OD; Me4Si (Refer Table 3.6) 
13
C-NMR   : 150 MHz; CD3OD; Me4Si (Refer Table 3.6) 
 
Vindogentianine (136)
97-101;105
 
N
Me
N
OCOMe
H
HO COOMe
H
11
10
9
12
13
8
7
2
6
5
3
14
1520
18
19'17
16
21
22
N
O
O
MeO
3'
4'
5'
6'7'
8'
1'
2'
9'10'
(136)  
Nature of isolate  : brown, amorphous solid 
Molecular formula  : C35H41N3O8 
Optical rotation  :     
   -134° (c 1.0, MeOH) 
UV (MeOH) λmax   : 216 (4.46), 259 (4.11) and 310 (4.01) nm 
IR (KBr) υmax    : 3458, 1741 and 1240 cm
-1
 
[M+H]
+
   : 632 m/z 
1
H-NMR   : 400 MHz; CDCl3; Me4Si (Refer Table 3.7) 
13
C-NMR   : 100 MHz; CDCl3; Me4Si (Refer Table 3.7) 
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